Notas - planetadelibros.com.ar€¦ · 1 Notas Prefacio 1. Abrams,D.:IntegrativeOncology[Oncologíainte- grativa],OxfordUniversityPress,2009. 2. Dhabhar, F. S. et al.: «High-anxious

1

Notas

Prefacio

1. Abrams, D.: Integrative Oncology [Oncología inte-grativa], Oxford University Press, 2009.

2. Dhabhar, F. S. et al.: «High-anxious individualsshow increased chronic stress burden, decreased protectiveimmunity, and increased cancer progression in a mouse mo-del of squamous cell carcinoma», PLoS One, 2012; nº 7 (4):e33069.

3. Spiegel, D.: «Mind matters in cancer survival», Psy-chooncology, 21 de junio de 2012; nº 6: pp. 588-593.

4. Antoni, M. H.: «The influence of bio-behaviouralfactors on tumour biology: Pathways and mechanisms»,Nat. Rev. Cancer, 6 de marzo de 2006; nº 6 (3): pp. 240-248.

5. Thaker, P. H.: «Chronic stress promotes tumorgrowth and angiogenesis in a mouse model of ovarian car-cinoma», Nat. Med., agosto de 2006; nº 12 (8): pp. 939-944.

6. Lutgendorf, S. K.: «Host factors and cancer pro-gression: Biobehavioral signaling pathways and interven-tions», J. Clin. Oncol., 10 de septiembre de 2010; nº 28 (26):pp. 4094-4099.

7. Shahzad, M. M.: «Stress effects on FosB- and inter-leukin-8 (IL8)-driven ovarian cancer growth and metásta-sis», J. Biol. Chem., 12 de noviembre de 2010; nº 285 (46):pp. 35462-35470.

8. Sood, A. K.: «Stress influences on anoikis», CancerPrev. Res. (Phila), abril de 2011; nº 4 (4): pp. 481-485.

024-109061-ANTICANCER EMOCIONES Notas.indd 1 29/05/13 13:44

2

9. Gidron, Y.: «Influence of stress and health-beha-viour on miRNA expression», Mol. Med. Report, mayo-junio de 2010; nº 3 (3): pp. 455-457.

10. Satin, J.: «Depression as a predictor of disease pro-gression and mortality in cancer patients: A meta-analysis»,Cancer, 2009; nº 115: pp. 5349-5361.

Chida, Y.: «Do stress-related psychosocial factors con-tribute to cancer incidence and survival?», Nat. Clin. Pract.Oncol., 2008; nº 5: pp. 466-475.

11. Andersen, B. L.: «Psychological intervention im-proves survival for breast cancer patients: A randomizedclinical trial», Cancer., 15 de diciembre de 2008; nº 113 (12):pp. 3450-3458.

12. Andersen, B. L.: «Biobehavioral, immune, andhealth benefits following recurrence for psychological in-tervention participants», Clin. Cancer. Res., 15 de junio de2010; nº 16 (12): pp. 3270-3278.

13. Deng, G. E.: «Evidence-based clinical practice gui-delines for integrative oncology: Complementary thera-pies and botanicals», J. Soc. Integr. Oncol., verano de 2009;nº 7 (3): pp. 85-120.

14. Deng, G. E.: «Integrative Cancer Care in a USAcademic Cancer Centre: The Memorial Sloan-KetteringExperience», Curr. Oncol., agosto de 2008; nº 15 supl. 2:pp. S68-S71.

15. Wesa, K.: « Integrative oncology: Complementarytherapies for cancer survivors», Hematol. Oncol. Clin.North. Am., abril de 2008; nº 22 (2): pp. 343-353, viii.

16. Richardson, M. A.: «Complementary/alternativemedicine use in a comprehensive cancer center and the im-plications for oncology», J. Clin. Oncol., julio de 2000;nº 18 (13): pp. 2505-2514.

17. Kligler, B.: «Cost savings in inpatient oncologythrough an integrative medicine approach», Am. J. Manag.Care, diciembre de 2011; nº 17 (12): pp. 779-784.


3

El poder anticáncer de las emociones.Preguntas frecuentes

1. Esta guía, publicada en inglés, titulada Evidence-Based Clinical Practice Guidelines for Integrative Oncolo-gy: Complementary Therapies and Botanicals, se puededescargar desde el sitio web de la SIO en: http://www.inte-grativeonc.org/index.php/sio-publishes-2009-practice-gui-delines.

Introducción

1. Becker, Robert O. y Gary Selden: The Body Elec-tric, New York, Harper, 1998.

2. Paradigmas de oncología

1. Dvorak, H. F.: «Tumors: wounds that do not heal.Similarities between tumor stroma generation and woundhealing», New England Journal of Medicine (NEJM),vol. 315, nº 26, 1986, pp. 1650-1659.

2. Harach, H. R.: «Occult papillary carcinoma of thethyroid. A “normal” finding in Finland. A systematic au-topsy study», Cancer, vol. 56, nº 3, 1985, pp. 531-538.

3. Servan-Schreiber, David: Anticancer. Prévenir etlutter grâce à nos défenses naturelles, Paris, Robert Laffont,2007. [Hay edición española: Anticáncer: una nueva formade vida, Espasa Calpe, 2010, ISBN 978-84-670-3515-5.]

3. El retorno de las emociones

1. Simonton, Carl: L’aventure d’une guérison, Bel-fond, 1993.

2. Leshan, L.: Cancer as a turning point, New York,E. P. Dutton, 1990. [Hay edición española: Luchar con elcáncer, Errepar, 1994, ISBN 9789507396083.]


4

3. Leshan, L.: «An Emotional Life-History PatternAssociated With Neoplastic Disease», Annals of the NewYork Academy of Sciences (Ann NY Acad Sci.), vol. 125,nº 3, 21 de enero de 1966, pp. 780-793.

4. Leshan, L. y M. A. Reznikoff: «A PsychologicalFactor Apparently Associated With Neoplastic Disease»,Journal of Abnormal and Social Psychology (J Abnorm SocPsychol.), vol. 60, mayo de 1960, pp. 439-440.

5. Leshan, L.: «Psychological States as Factors in theDevelopment of Malignant Disease: A Critical Review»,Journal of the National Cancer Institute (JNCI), vol. 22,nº 1, enero de 1959, pp. 1-18.

6. Bahnson, C. B. y M. B. Bahnson: «Role of the EgoDefenses: Denial and Repression in the Etiology of Malig-nant Neoplasm», Ann NY Acad Sci., vol. 125, nº 3, 21 deenero de 1966, pp. 827-845.

7. Reiser, M.: «Psychophysiological Aspects of Can-cer. Retrospects and Prospects», Ann NY Acad Sci.,vol. 125, nº 3, 21 de enero de 1966, pp. 1028-1055.

8. Reich, W.: The Cancer Biopathy, New York, Fa-rrar, Straus and Giroux, 1971.

9. Guinée, Robert: Les maladies, mémoires del’évolution, Bruselas, Éditions Amyris, 2004.

10. Moirot, Michel: Origine des cancers, París, LesLettres Livres, 1985, edición digital.

11. Thomas, C. B. y R. L. Greenstreet: «Psychobiolo-gical characteristics in youth as predictors of five diseasestates: suicide, mental illness, hypertension, coronary heartdisease and tumor», Johns Hopkins Medical Journal,vol. 132, nº 1, enero de 1973, pp. 16-43.

12. Thomas, C. B. y K. R. Duszynski: «Closeness to pa-rents and the family constellation in a prospective study offive disease states: suicide, mental illness, malignant tumor,hypertension, and coronary heart disease», Johns HopkinsMedical Journal, vol. 134, nº 5, mayo de 1974, pp. 251-270.

13. Thomas, C. B., K. R. Duszynski y J. W. Shaffer:«Family attitudes reported in youth as potential predictors ofcancer», Psychosomatic Medicine (Psychosom Med), vol. 41,nº 4, junio de 1979, pp. 287-302.


5

14. Harrower, M., C. B. Thomas y A. Altman: «Hu-man figure drawings in a prospective study of six disorders:hypertension, coronary heart disease, malignant tumor,suicide, mental illness, and emotional disturbance», TheJournal of Nervous and Mental Disease (J Nerv Ment Dis.),vol. 161, nº 3, septiembre de 1975, pp. 191-199.

15. Grossarth-Maticek, R.: «Psychosocial factors asstrong predictions of mortality from cancer, ischemic heartdisease and stroke: Yugoslav Prospective Study», Journalof Psychosomatic Research, vol. 29, 1985, pp. 167-176.

16. Grossarth-Maticek, R.: «Cancer and family struc-ture», Familien dynamik, vol. 21, nº 4, 1976, pp. 294-318.

17. Grossarth-Maticek, R.: «Prophylactic effects ofpsychoanalysis on cancer-prone probands, as comparedwith control groups and behavior therapy groups», Jour-nal of Behavior Therapy and Experimental Psychiatry(J. Behav. Ther. and Exp. Psychiat.), vol. 21, nº 2, 1990,pp. 91-99.

18. Grossarth-Maticek, R.: «Sport activity and per-sonality as elements in preventing cancer and coronaryheart disease», Perceptual and Motor Skills, vol. 71, 1990,pp. 199-209.

19. Grossarth-Maticek, R.: «Creative novation beha-viour therapy as a prophylactic treatment for cancer andcoronary heart disease: Part I – Description of treatment»,Behavior Research and Therapy (Behav. Res. Ther.),vol. 29, nº 1, 1991, pp. 1-16.

20. Grossarth-Maticek, R.: «Creative novation beha-viour therapy as a prophylactic treatment for cancer andcoronary heart disease: Part II – Effects of treatment»,Behav. Res. Ther., vol. 29, nº 1, 1991, pp. 17-31.

21. Grossarth-Maticek, R.: «Interaction of psychoso-cial and physical risk factors in the causation of mammarycancer, and its prevention through psychological methodsof treatment», Journal of Clinical Psychology, vol. 56, nº 1,2000, pp. 33-50.

22. Grossarth-Maticek, R. y H. J. Eysenck: «Length ofsurvival and lymphocyte percentage in women with mam-mary cancer as a function of psychotherapy», Psychological


6

Reports (Psychol Rep.), vol. 65, nº 1, agosto de 1989,pp. 315-321.

23. Grossarth-Maticek, R., R. Frentzel-Beyme y N.Becker: «Cancer risks associated with life events and con-flicts solution», Cancer Detection and Prevention (CancerDetect Prev), vol. 7, 1984, pp. 201-209.

24. Eysenck, H. J.: «Health’s character», PsychologyToday, vol. 22, diciembre de 1989, pp. 28-32.

25. Spiegel, D. et al.: «The effect of psychosocialtreatment on survival of patients with metastatic breastcancer», The Lancet, vol. II, nº 8668, 14 de octubre de 1989,pp. 888-891.

26. Simonton, O. C.: Getting Well Again, Los Ange-les, Tarcher, 1978.

27. Simonton, O. C.: The Healing Journey, AuthorsChoice Press, 2002.

28. Simonton, O. C.: «Psychological InterventionTreatment of Cancer», Psychosomatics, vol. 21, nº 3, 1980,pp. 231-233.

29. Evans, E.: A Psychological Study of Cancer, NewYork, Dodd, Mead, 1926.

30. Blumberg, E. M.: «Results of psychological testingof cancer patients», The Psychological Variables in HumanCancer, Berkeley y Los Angeles, University of CaliforniaPress, 1954, pp. 30-61.

31. Reznikoff, M.: «Psychological factors in breastcancer: A preliminary study of some personality trends inpatients with cancer of the breast», Psychosom Med, vol. 17,1955, pp. 96-108.

32. Klopfer, B.: «Psychological variables in human can-cer», Journal of Projective Techniques, vol. 21, pp. 331-340.

33. Greene, W. A.: «Psychological factors and reticulo-endothelial disease», Psychosom Med, vol. 20, pp. 124-144.

34. Kissen, D. M.: Lung cancer, inhalation and perso-nality: Psychosomatic aspects of neoplastic disease, Filadel-fia, J. B. Lippincott, 1963.

35. Schmale, A. H. y H. Iker: «The psychological set-ting of uterine cervical cancer», Ann NY Acad Sci., vol. 125,1966, pp. 807-813.


7

36. Giovacchini, P. L. y H. Muslin: «Ego equilibriumand cancer of the breast», Psychosom Med, vol. 27, nº 6,noviembre-diciembre 1965, pp. 524-532.

37. Derogatis, L.: «Psychological coping mechanismsand survival time in metastatic breast cancer», Journal ofthe American Medical Association (JAMA), vol. 242, 1979,pp. 1504-1508.

38. Dattore, P. J.: «Premorbid personality differen-tiation of cancer and noncancer groups: A test of the hypo-thesis of cancer proneness», Journal of Consulting and Cli-nical Psychology (J Consul Clin Psychol), vol. 48, 1980,pp. 388-394.

39. Greer, S.: «Cancer and the Mind», Soc Sci Med,vol. 20, 1985, pp. 771-853.

40. Pettingale, K. W.: «Mental attitude to cancer: Anadditional prognostic factor», The Lancet, vol. 1, 1985, p. 750.

41. Temoshok, L.: «Personality, coping style, emo-tions and cancer: Towards an integrative model», CancerSurveys, vol. 6, nº 3, 1987, pp. 545-567.

42. Redd, W. H. y P. B. Jacobsen: «Emotions and can-cer: New perspectives on an old question», Cancer, vol. 62,1988, pp. 1871-1879.

43. Levy, S. M.: «Survival hazards analysis in first re-current breast cancer patients: Seven-year follow-up», Psy-chosom Med, vol. 50, nº 5, 1998, pp. 520-528.

44. Smith, E.: «Fighting cancerous feelings», Psycholo-gy Today, mayo de 1988, pp. 22-23.

45. Gross, J.: «Emotional expression on cancer onsetand progression», Soc Sci Med, vol. 28, nº 12, 1989,pp. 1238-1248

46. Stein, S., M. W. Linn y E. M. Stein: «Psychologicalcorrelates of survival in nursing home cancer patients», Ge-rontologist, vol. 29, nº 2, abril de 1989, pp. 224-228.

47. Zevon, M. A. y B. Corn: Annual Congress of theAmerican Psychological Association, Boston, 1990.

48. Linkins, R. W. y G. W. Comstock: «Depressedmood and development of cancer», American Journal ofEpidemiology (Am J Epidemiol), vol. 132, nº 5, 1990,pp. 962-972.


8

49. Jasmin, C., M. G. Le, P. Marry y R. Herzberg:«Evidence for a link between certain psychological factorsand the risk of breast cancer in a case-control study», An-nals of Oncology (Ann Oncol), vol. 1, 1990, pp. 22-29.

50. Brissette, Y.: «Le cancer: Au-delà des idées reçues»,La filière émotionnelle, Psychologie préventive, vol. 19,1991, pp. 15-21.

51. Baltrusch, H. J., W. Stangel e I. Titze: «Stress, can-cer and immunity. New developments in biopsychosocialand psychoneuroimmunologic research», Acta Neurologi-ca (Napoli), vol. 13, nº 4, agosto de 1991, pp. 315-327.

52. Fawzy, F. I., M. E. Kemeny, N. W. Fawzy et al.:«A structured psychiatric intervention for cancer patients:II. Changes over time in immunological measures», Archi-ves of General Psychiatry (Arch Gen Psychiatry), vol. 47,nº 8, agosto de 1990, pp. 729-735.

53. Fawzy, F. J., N. W. Fawzy, C. S. Hyun et al.:«Malignant melanoma: Effects of an early structured psy-chiatric intervention, coping and affective state on recu-rrence and survival 6 years later», Arch Gen Psychiatry,vol. 50, nº 9, septiembre de 1993, pp. 681-689.

54. Fox, C. M., A. P. Harper, G. C. Hyner y R. M.Lyle: «Loneliness, emotional repression, marital quality,and major life events in women who develop breast can-cer», Journal of Community Health, vol. 19, nº 6, diciembrede 1994, pp. 467-482.

55. Bryla, C. M.: «The relationship between stress andthe development of breast cancer: A literature review», On-cology Nursing Forum (ONF), vol. 23, nº 3, abril de 1996,pp. 441-448.

56. Penninx, B. W. et al.: «Chronically depressed moodand cancer risk in older persons», JNCI, vol. 90, nº 24, 16 dediciembre de 1998, pp. 1888-1893.

57. Faller, H.: «Coping, distress and survival amongpatients with lung cancer», Arch Gen Psychiatry, vol. 56,1999, pp. 756-762.

58. Walker, L. G.: «Psychological factors can predictthe response to primary chemotherapy in patients withlocally advanced breast cancer», European Journal of Can-


9

cer (Eur J Cancer), vol. 35, nº 13, diciembre de 1999,pp. 1783-1788.

59. Watson, M.: «Influence of psychological respon-se on survival in breast cancer: A population-based co-hort study», The Lancet, vol. 354, nº 9187, 1999, pp. 1331-1336.

60. Reynaert, C.: «Psychogenèse du cancer: Entremythes, abus et réalité», Bulletin du cancer, vol. 87, nº 9,2000, pp. 655-664.

61. Price, M. A.: «The role of psychosocial factors inthe development of breast carcinoma: Part II. Life eventstressors, social support, defense style, and emotional con-trol and their interactions», Cancer, vol. 91, nº 4, 2001,pp. 686-697.

62. Brown, K.: «Psychological distress and cancer sur-vival: A follow-up 10 years after diagnosis», PsychosomMed, vol. 65, 2003, pp. 636-643.

63. Lillberg, K. et al.: «Stressful life events and risk ofbreast cancer in 10 808 women: A cohort study», AmericanJournal of Epidemiology, vol. 157, nº 5, 1 de marzo de 2003,pp. 415-423.

64. Reiche, E. M. V.: «Stress, depression, the immunesystem, and cancer», Lancet Oncology, vol. 5, nº 10, 2004,pp. 617-625.

65. Cunningham, A. J. y K. Watson: «How psycholo-gical therapy may prolong survival in cancer patient: Newevidence and a simple theory», Integrative Cancer Thera-pies (Integr Cancer Ther), vol. 3, nº 3, septiembre de 2004,pp. 214-229.

66. Ornish, D.: «Intensive lifestyle changes may affectthe progression of prostate cancer», Journal of Urology,vol. 174, nº 3, 2005, pp. 1065-1069, discussion 9-70.

67. Ollonen, P., Lehtonen, J. y M. Eskelinen: «Copingand defending as risk factors for breast cancer in patientswith breast disease: A prospective case-control study inKuopio, Finland», Anticancer Research, vol. 25, nº 6C, no-viembre-diciembre de 2005, pp. 4623-4630.

68. Nakaya, N. et al.: «Personality traits and cancersurvival: A Danish cohort study», British Journal of Cancer


10

(Br J Cancer), vol. 95, nº 2, 17 de julio de 2006 (publicaciónelectrónica: 4 de julio de 2006), pp. 146-152.

69. Beresford, T.: «Cancer survival probability as afunction of ego defense (adaptive) mechanisms versus depres-sive symptoms», Psychosomatics, vol. 47, 2006, pp. 247-253.

70. Nagano, J.: «A prospective Japanese study of theassociation between personality and the progression oflung cancer», Inter Med, vol. 45, nº 2, 2006, pp. 57-63.

71. Zozulya, A. A., M. V. Gabaeva, O. Y. Sokolov etal.: «Personality, coping style, and constitutional neuroim-munology», Journal of Immunotoxicology (J Immunotoxi-col.), vol. 5, nº 2, abril de 2008, pp. 221-225.

72. Tran, E., F. Rouillon, J. Y. Loze et al.: «Cancermortality in patients with schizophrenia: An 11-year pros-pective cohort study», Cancer, vol. 115, nº 15, 1 de agostode 2009, pp. 3555-3562.

73. Sanzo, M., R. Colucci, R., M. Arunachalam et al.:«Stress as a possible mechanism in melanoma progression»,Dermatology Research and Practice (Dermatol Res Pract),vol. 2010, 15 de marzo de 2010 (publicación electrónica:27 de mayo de 2010), pp. 483-493.

74. Giese-Davis, J., K. Collie, K. M. Rancourt et al.:«Decrease in depression symptoms is associated with lon-ger survival in patients with metastatic breast cancer: a se-condary analysis», Journal of Clinical Oncology (J ClinOncol), vol. 29, nº 4, 1 de febrero de 2011 (publicación elec-trónica: 13 de diciembre de 2010), pp. 413-420.

75. Banyan, Calvin D.: The Secret Language of Fee-lings: A Rational Approach to Emotional Mastery, Califor-nia, Banyan Hypnosis Center, 2002.

76. Ader, R.: Psychoneuroimmunology, New York,Academic Press, 1926.

77. Lutgendorf, S. K.: «Social support, psychologicaldistress, and natural killer cell activity in ovarian cancer»,Journal of Clinical Oncology (J Clin Oncol), vol. 23, nº 28,2005, pp. 7105-7113.

78. Marucha, P. T.: «TNF-alpha levels in cancer pa-tients relate to social variables», Brain, Behavior, and Im-munity, vol. 19, nº 6, noviembre de 2005, pp. 521-525.


11

79. Glaser, R.: «Stress depresses interferon produc-tion by leukocytes concomitant with a decrease in NaturalKiller Cell Activity», Behavioral Neuroscience, vol. 199,pp. 675-678.

80. Levy, S.: «Correlation of stress factors with sustai-ned depression of natural killer cell activity and predictedprognosis in patients with breast cancer», Journal of Clini-cal Oncology (J Clin Oncol), vol. 5, nº 3, 1987, pp. 348-353.

81. Irwin, M., M. Daniels, S. C. Risch et al.: «Plasmacortisol and natural killer cell activity during bereavement»,Biological Psychiatry (Biol Psychia), vol. 24, nº 2, junio de1988, pp. 173-178.

82. Ben-Eliyahu, S.: «Suppression of NK cell activityand of resistance to metastasis by stress: A role for adrenalcatecholamines and beta-adrenoceptors», Neuroimmuno-modulation, vol. 8, nº 3, 2000, pp. 154-164.

83. Kiecolt-Glaser, J. K.: «Psycho-oncology and can-cer: Psychoneuroimmunology and cancer», Ann Oncol.,vol. 13, suppl. 4, 2002, pp. 165-169

84. Cohen, M. y Pollack, S.: «Mothers with breast can-cer and their adultdaughters: The relationship between mo-thers’ reaction to breast cancer and their daughters’ emotio-nal and neuroimmune status», Psychosom Med, vol. 67, nº 1,enero-febrero de 2005, pp. 64-71.

85. Kovács, Z. A., L. G. Puskás, A. Juhász et al.: «Hyp-nosis upregulates the expression of immune-related genesin lymphocytes», Psychotherapy and Psychosomatics,vol. 77, nº 4, 2008 (publicación electrónica: 25 de abril de2008), pp. 257-259.

86. Hall, H. R.: «Hypnosis and the immune system: Areview with implications for cancer and the psychology ofhealing», American Journal of Clinical Hypnosis (Am J ClinHypn), vol. 25, nº 2-3, octubre de 1982-enero de 1983,pp. 92-103.

87. Kiecolt-Glaser, J. K., R. Glaser, D. Wiliger et al.:«Psychosocial enhancement of immunocompetence in a ge-riatric population», Health Psychology, vol. 4, 1985, pp. 25-41.

88. Kiecolt-Glaser, J. K. y R. Glaser: «Psychoneuro-immunology: Can psychological interventions modulate


12

immunity?», Journal of Consulting and clinical Psychology(J Consul Clin Psychol), vol. 60, 1992, pp. 569-575.

89. Bennett, M. P.: «The effect of mirthful laughter onstress and natural killer cell activity», Alternative Therapiesin Health and Medicine (Altern Ther Health Med), vol. 9,nº 2, marzo-abril de 2003, pp. 38-45.

90. Berk, L.: «Humor associated laughter decreasescortisol and increases spontaneous lymphocyte blastogene-sis», Clinical Research, vol. 36, 1988, p. 435 (extracto).

91. Antoni, M. H.: «The influence of bio-behaviouralfactors on tumour biology: Pathways and mechanisms»,Nature Reviews Cancer, vol. 6, nº 3, 2006, pp. 240-248.

92. Thaker, P. H.: «The neuroendocrine impact ofchronic stress on cancer», Seminars in Cancer Biology,vol. 18, nº 3, 2008, pp. 164-170.

93. Thaker, P. H., S. K. Lutgendorf y A. K. Sood: «Theneuroendocrine impact of chronic stress on cancer», CellCycle, vol. 6, nº 4, 15 de febrero de 2007 (publicación elec-trónica: 9 de febrero de 2007), pp. 430-433.

94. Thaker, P. H. y A. K. Sood: «The NeuroendocrineImpact of Chronic Stress on Cancer», Seminars in CancerBiology, vol. 18, nº 3, junio de 2008, pp. 164-170.

95. Shahzad, M. M., J. M. Arevalo, G. N. Armaiz-Penaet al.: «Stress effects on FosB-and interleukin-8 (IL8)-dri-ven ovarian cancer growth and metastasis», The Journal ofBiological Chemistry (J Biol Chem), vol. 285, nº 46, 12 denoviembre de 2010 (publicación electrónica: 8 de septiem-bre de 2010), pp. 35462-35470.

96. Visintainer, M. A., J. R. Volpicelli y M. E. Selig-man: «Tumor rejection in rats after inescapable or escapa-ble shock», Science, vol. 216, nº 4544, 23 de abril de 1982,pp. 437-439.

97. Yang, E. V., S. J. Kim, E. L. Donovan et al.: «Nor-epinephrine upregulates VEGF, IL-8, and IL-6 expressionin human melanoma tumor cell lines: Implications forstress-related enhancement of tumor progression», Brain,Behavior, and Immunity (Brain Behav Immun), vol. 23,nº 2, febrero de 2009 (publicación electrónica: 21 de octu-bre de 2008), pp. 267-275.


13

98. Yang, E. V., A. K. Sood, M. Chen et al.: «Norepi-nephrine up-regulates the expression of vascular endothe-lial growth factor, matrix metalloproteinase (MMP)-2, andMMP-9 in nasopharyngeal carcinoma tumor cells», CancerResearch, vol. 66, nº 21, 1 de noviembre de 2006, pp. 10357-10364.

99. Moreno-Smith, M., C. Lu, M. M. Shahzad et al.:«Dopamine blocks stress mediated ovarian carcinomagrowth», Clinical Cancer Research, vol. 17, nº 11, 1 de ju-nio de 2011 (publicación electrónica: 29 de abril de 2011),pp. 3649-3659.

100. Lutgendorf, S. K., S. Cole, E. Costanzo et al.:«Stress-related mediators stimulate vascular endothelialgrowth factor secretion by two ovarian cancer cell lines»,Clinical Cancer Research, vol. 9, nº 12, 1 de octubre de2003, pp. 4514-4521.

101. Sastry K. S., Y. Karpova, S. Prokopovich et al.:«Epinephrine protects cancer cells from apoptosis via acti-vation of cAMP-dependent protein kinase and BAD phos-phorylation», J Biol Chem, vol. 282, nº 19, 11 de mayo de2007 (publicación electrónica: 12 de marzo de 2007),pp. 14094-14100.

102. Sood A. K., R. Bhatty, A. A. Kamat et al.: «Stresshormone-mediated invasion of ovarian cancer cells», Clini-cal Cancer Research, vol. 12, nº 2, 15 de enero de 2006,pp. 369-375.

103. Giraldi T., L. Perissin, S. Zorzet y V. Rapozzi: «Ro-tational stress reduce the effectiveness of antitumor drugs inmice», Ann NY Acad Sci, vol. 741, 1994, pp. 234-243.

104. Saul A. N., T. M. Oberyszyn, C. Daugherty et al.:«Chronic stress and susceptibility to skin cancer», JNCI,vol. 97, nº 23, 7 de diciembre de 2005, pp. 1760-1767.

105. Jung, W. y M. Irwin: «Reduction of natural killercytotoxic activity in major depression: Interaction betweendepression and cigarette smoking», Psychosom Med,vol. 61, 1999, pp. 263-270.

106. Sloan E. K., S. J. Priceman, B. F. Cox et al.: «Thesympathetic nervous system induces a metastatic switch inprimary breast cancer», Cancer Research, vol. 70, nº 18, 15 de


14

septiembre de 2010 (publicación electrónica: 7 de septiem-bre de 2010), pp. 7042-7052.

107. Perron L., I. Bairati, F. Harel y F. Meyer: «Anti-hypertensive drug use and the risk of prostate cancer (Ca-nada)», Cancer Causes and Control, vol. 15, nº 6, agosto de2004, pp. 535-541.

108. Algazi M., G. Plu-Bureau, A. Flahault et al.: «Couldtreatments with b-blockers be associated with a reduction incancer risk?», Revue d’épidémiologie et de santé publique,vol. 52, 2004, pp. 53-65.

109. Feldman, Robert: Introduction à la psychologie.Approches contemporaines, Montreal, Chenelière/McGraw-Hill, 1993.

110. Kreinin, A., D. Novitski et al.: «Associationbetween tobacco smoking and bipolar affective disorder:Clinical, epidemiological, cross-sectional, retrospectivestudy in outpatients», Comprehensive Psychiatry, vol. 53,nº 3, 2012 (publicación elctrónica: 9 de junio de 2011),pp. 269-274.

111. Kao, Y. C., Y. P. Liu, T. H. Cheng y M. K. Chou:«Cigarette smoking in outpatients with chronic schizo-phrenia in Taiwan: Relationships to socio-demographicand clinical characteristics», Psychiatry Research, vol. 190,nº 2-3, diciembre de 2011 (publicación elctrónica: 27 demayo de 2011), pp. 193-199.

112. Acartürk, C. Z. y V. Nierkens: «Depressivesymptoms and smoking among young Turkish and Moroc-can ethnic minority groups in The Netherlands: A cross-sectional study», Substance Abuse Treatment, Prevention,and Policy (Subst. Abuse Treat. Prev. Policy), vol. 6 nº 1,17 de marzo de 2011, p. 5.

113. Pert, Candace: Molecules of Emotion, New York,Scribner, 1997.

114. Radin, D. I.: «Gut Feelings, Intuition, and Emo-tions: An Exploratory Study», The Journal of Alternativeand Complementary Medicine, vol. 11, nº 1, 2005, pp. 85-91.

115. Zipser, B., M. R. Ruff, J. B. O’Neill et al.: «Theopiate receptor: A single 110 kDa recognition moleculeappears to be conserved in Tetrahymena, leech, and rat»,


15

Brain Research, vol. 463, nº 2, 1 de noviembre de 1988,pp. 296-304.

4. Más allá de las fronteras

1. Descartes, René: Los principios de la filosofía, 1644.2. Beauregard, Mario y Denyse O’Leary: Du cerveau

à Dieu, París, Guy Trédaniel Éditeur, 2008.3. Darwin, Charles: La variación de los animales y las

plantas bajo domesticación, 1868.4. Darwin, Charles: El origen de las especies, 1859.5. Kelly, Robin: The Human Antenna, California,

Energy Psychology Press, 2008.6. Mctaggart, Lynne: The Field, New York, Harper

Perennial, 2002.7. Grousson, Mathieu: «La vie serait quantique!»,

Science et Vie, nº 1123, abril de 2011, p. 59.8. Church, Dawson: The Genie in your Genes, Cali-

fornia, Energy Psychology Press, 2008.9. Dufour, Daniel: Les tremblements intérieurs,

Montreal, Les Éditions de l’Homme, 2003.10. Braden, Gregg: The Divine Matrix, California, Hay

House, 2007.11. http://www.cbc.ca/news/health/story/2011/05/20/

technology-interaxon-thought-controlled-video-games.html12. http://news.bbc.co.uk/2/hi/technology/7254078.stm

5. Epigenética: los genes no modelan nuestrodestino

1. Kelly, Robin: The Human Antenna, California,Energy Psychology Press, 2008.

2. Sheldrake, Rupert: A New Science of Life, Londres,Icon Books, 2009.

3. Nakagaki, T.: «Smart behavior of true slime mold ina labyrinth», Research in Microbiology (Res Microbiol),vol. 152, nº 9, noviembre de 2001, pp. 767-770.


16

4. Pershin, Y. V., S. La Fontaine y M. di Ventra:«Memristive model of amoeba learning», Physical Review E,vol. 80, nº 2, agosto de 2009 (publicación electrónica: 21 deagosto de 2009), 019909.


6. Andersen, U. S. Three Magic Words, California,Wilshire Book Co., 1954.

7. Darwin, Charles: La variación de los animales y lasplantas bajo domesticación, 1868.

8. Darwin, Charles. El origen de las especies, 1859.9. Koonin et al.: «Is evolution darwinian or/and La-

marckian?», Biology Direct, vol. 4, 11 de noviembre de2009, p. 42.

10. Church, Dawson. The Genie in your Genes, Cali-fornia, Energy Psychology Press, 2008.

11. Lichtenstein, Paul: «Environmental and heritablefactors in the causation of cancer: Analyses of cohorts oftwins from Sweden, Denmark, and Finland», NEJM,vol. 343, nº 2, 2000, pp. 78-85.

12. Sorensen, T.: «Genetic and environmental influen-ces on premature death in adult adoptees», NEJM, vol. 318,nº 12, 1988, pp. 727-732.

13. Lipton, Bruce: The Biology of Belief, California,Hay House, 2005.

14. Hitchins, M. P.: «Inheritance of epigenetic aberra-tions (constitutional epimutations) in cancer susceptibi-lity», Advances in Genetics (Adv Genet), vol. 70, 2010,pp. 201-243.

15. Dobrovic, A. y L. S. Kristensen: «DNA methyla-tion, epimutations and cancer predisposition» The Inter-national Journal of Biochemistry and Cell Biology (Int JBiochem Cell Biol), vol. 41, nº 1, 1 de enero de 2009 (publica-ción electrónica: 16 de septiembre de 2008), pp. 34-39.

16. Reik, W. y J. Walter: «Genomic imprinting: Paren-tal influence on the genome», Nature Reviews Genetics,vol. 2, nº 1, enero de 2001, pp. 21-32.

17. Dean, W. L., G. Kelsey y W. Reik: «Generation ofmonoparental embryos for investigation into genomic im-


17

printing», Methods in Molecular Biology, vol. 181, 2001,pp. 1-19.

18. Latham, K. E.: «Epigenetic modification and im-printing of the mammalian genome during development»,Current Topics in Developmental Biology (Curr Top DevBiol), vol. 43, 1999, pp. 1-49.

19. Woodfine, K., J. E. Huddleston y A. Murrell:«Quantitative analysis of DNA methylation at all humanimprinted regions reveals preservation of epigenetic stabili-ty in adult somatic tissue», Epigenetics Chromatin, vol. 4,nº 1, 31 de enero de 2011, pp. 1-13.

20. Olszewska, M. y M. Kurpisz: «Methylation ofDNA is an epigenetic modifycation critical for gametic im-printing», Post py Higieny i Medycyny Do wiadczalnej(Postepy Hig Med Dosw), [en línea], vol. 64, 7 de diciembrede 2010, pp. 642-649.

21. Kawai, T. et al.: «Gene expression signature in pe-ripheral blood cells from medical students exposed to chro-nic psychological stress», Biological Psychology (Biol Psy-chol), vol. 67, nº 3, octubre de 2007 (publicación electrónica:31 de julio de 2007), pp. 147-155.

22. Ornish, D. et al.: «Changes in prostate gene ex-pression in men undergoing an intensive nutrition and life-style intervention», Proceedings of the National Academy ofSciences, vol. 105, nº 24, 17 de junio de 2008, pp. 8369-8374.

23. Johnstone, S. et al.: «Stress and the epigeneticlandscape: A link to the path biology of human diseases?»,Nature Reviews Genetics, vol. 11, nº 11, noviembre de 2010,pp. 806-812.

24. McGowan, P. O., A. Sasaki, T. C. Huang et al.:«Promoter-wide hypermethylation of the ribosomal RNAgene promoter in the suicide brain», PLoS One, vol. 3, nº 5,7 de mayo de 2008, e2085.

25. McGowan, P. O., M. J. Meaney y M. Szyf: «Dietand the epigenetic (re) programming of phenotypic diffe-rences in behavior», Brain Research, vol. 1237, 27 oct. 2008(publicación electrónica: 29 de Julio de de 2008), pp. 12-24.

26. Braden, Gregg: The Divine Matrix, California,Hay House, 2007.


18

27. Poulter M. O., L. Du, I. C. Weaver et al.: «GA-BAA receptor promoter hypermethylation in suicidebrain: Implications for the involvement of epigenetic pro-cesses», Biological Psychiatry (Biol. Psychiatry), vol. 64,nº 8, 15 de octubre de 2008 (publicación electrónica: 18 dejulio de 2008), pp. 645-652.

28. Cwikel, J. G., Y. Gidron y M. Quastel: «Low-doseenvironmental radiation, DNA damage, and cancer: Thepossible contribution of psychological factors», Psycholo-gy, Health and Medicine (Psychol Health Med), vol. 15,nº 1, enero de 2010, pp. 1-16.

29. Mathers, J. C., G. Strathdee y C. L. Relton: «In-duction of epigenetic alterations by dietary and other envi-ronmental factors», Adv Genet, vol. 71, 2010, pp. 3-39.

30. Mathews, H. L. y L. W. Janusek: «Epigenetics andpsychoneuroimmunology: Mechanisms and models», Brain,Behavior, and Immunity (Brain Behav Immun), vol. 25,nº 1, enero de 2011 (publicación electrónica: 9 de septiem-bre de 2010), pp. 25-39.

31. Trainor, B. C., C. Sweeney y R. Cardiff: «Isola-ting the effects of social interactions on cancer biology»,Cancer Prevention Research, vol. 2, nº 10, octubre de 2009(publicación electrónica: 29 de septiembre de 2009),pp. 843-846.

32. Shahzad, M. M., J. M. Arevalo y A. K. Sood: «Stresseffects on FosBand interleukin-8 (IL8)-driven ovarian can-cer growth and metastasis», J Biol Chem, vol. 285, nº 46,12 de noviembre de 2010 (publicación electrónica: 8 de sep-tiembre de 2010), pp. 35462-35470.

33. Sanzo, M., R. Colucci, M. Arunachalam et al.:«Stress as a possible mechanism in melanoma progression»,Dermatol Res Pract, vol. 2010, (publicación electrónica:27 de mayo de 2010), pp. 483-493.

34. Williams, J. B., D. Pang, B. Delgado. et al.: «A mo-del of gene-environment interaction reveals altered mam-mary gland gene expression and increased tumor growthfollowing social isolation», Cancer Prevention Research,vol. 2, nº 10, octubre de 2009 (publicación electrónica: 29 deseptiembre de 2009), pp. 850-861.


19

35. Thaker, P. H. y A. K. Sood: «Neuroendocrine in-fluences on cancer biology», Seminars in Cancer Biology,vol. 18, nº 3, junio de 2008 (publicación electrónica: 8 dediciembre de 2007), pp. 164-170.

36. Landen Jr., C. N., Y. G. Lin, G. N. Armaiz Pena etal.: «Neuroendocrine modulation of signal transducer andactivator of transcription-3 in ovarian cancer», Cancer Re-search, vol. 67, nº 21, 1 de noviembre de 2007, pp. 10389-10396.

37. Yang, E. V., A. K. Sood, M. Chen et al.: «Norepi-nephrine up-regulates the expression of vascular endothe-lial growth factor, matrix metalloproteinase (MMP)-2, andMMP-9 in nasopharyngeal carcinoma tumor cells», CancerResearch, vol. 66, nº 21, 1 de noviembre de 2006, pp. 10357-10364.

38. Sood, A. K., R. Bhatty, A. A. Kamat et al.: «Stresshormone-mediated invasion of ovarian cancer cells», Clini-cal Cancer Research, vol. 12, nº 2, 15 de enero de 2006,pp. 369-375.

39. Yin, D., Y. Zhang, C. Stuart et al.: «Chronic res-traint stress modulates expression of genes in murinespleen», Journal of Neuroimmunology (J Neuroimmunol),vol. 177, nº 1-2, agosto de 2006 (publicación electrónica:30 de junio de 2006), pp. 11-17.

40. Rein, H.: «Emotional energetics, intuition and epi-genetics research», The Institute of HeartMath.

41. Mathews, H. L., T. Konley, K. L. Kosik et al.:«Epigenetic patterns associated with the immune deregula-tion that accompanies psychosocial distress», Brain BehavImmun, vol. 55, nº 5, julio de 2011 (publicación electrónica:10 de diciembre de 2010), pp. 830-839.

42. Krukowski, K., J. Eddy, K. L. Kosik et al.: «Glu-cocorticoid dysregulation of natural killer cell functionthrough epigenetic modification», Brain Behav Immun,vol. 25, nº 2, febrero de 2011 (publicación electrónica: 23 dejulio de 2010), pp. 239-249.

43. Yehuda, R.: «Gene expression patterns associatedwith posttraumatic stress disorder following exposure tothe World Trade Center attacks», Biological Psychiatry,


20

vol. 66, nº 7, 1 de octubre de 2009 (publicación electrónica:25 de abril de 2009), pp. 708-711.

44. Hayashi, T. y K. Murakami: «The effects oflaughter on post-prandialglucose levels and gene expres-sion in type 2 diabetic patients», Life Sciences, vol. 85,nº 5-6, 31 de julio de 2009 (publicación electrónica: 18 demayo de 2009), pp. 185-187.

45. Cole, S. W. et al.: «Social regulation of gene expres-sion in human leukocytes», Genome Biology, vol. 8, 2007,p. 189.

46. Adachi, S., K. Kawamura y K. Takemoto. «Oxida-tive damage of nuclear DNA in liver of rats exposed to psy-chological stress», Cancer Research, vol. 53, nº 18, 15 deseptiembre de 1993, pp. 4153-4155.

47. Berton, O., C. A. McClung, R. J. Dileone et al.:«Essential role of BDNF in the mesolimbic dopamine path-way in social defeat stress», Science, vol. 311, nº 5762, 10 defebrero de 2006, pp. 864-868.

48. Wilkinson, M. B., G. Xiao, A. Kumar et al.: «Imi-pramine treatment and resiliency exhibit similar chromatinregulation in the mouse nucleus accumbens in depressionmodels», The Journal of Neuroscience (J Neurosci), vol. 29,nº 24, 17 de junio de 2009, pp. 7820-7832.

49. Dusek, J. A. et al.: «Genomic counter-stress chan-ges induced by the relaxation response», PLoS One, vol. 3,nº 7, 2 de julio de 2008, p. 2576.

50. Rossi, E. et al.: «A pilot study of positive expecta-tions and focused attention via a new protocol for optimi-sions therapeutic hypnosis and psychotherapy and assessedwith DNA Microarrays: The creative psychosocial Geno-mic Healing experience», Sleep and Hypnosis, vol. 10, nº 2,2008, pp. 39-44.

51. McCraty, R. et al.: «Modulation of DNA confor-mation by heart-focused intention», Institute of HeartMa-th Research Center, nº 03-008, 2003.

52. Weinhold, B: «Epigenetics: The Science of Chan-ge», Environmental Health Perspectives, vol. 114, nº 3,marzo de 2006, pp. A160-A167.

53. Willett, W. C.: «Balancing life-style and genomics


21

research for disease prevention», Science, vol. 296, nº 5568,26 de abril de 2002, pp. 695-698.

54. Lambert, M. P. y Z. Herceg: «Epigenetics andcancer, II Encuentro IARC, Lyon, Francia, 6 y 7 de di-ciembre de 2007», Molecular Oncology, vol. 2, nº 1, juniode 2008 (publicación electrónica: 27 de marzo de 2008),pp. 33-40.

55. Matthews, S. G. y D. I. Phillips: «Transgeneratio-nal Inheritance of Stress Pathology», Experimental Neuro-logy, vol. 233, nº 1, enero de 2012 (publicación electrónica:28 de enero de 2011), pp. 95-101.

56. Reul, J. M. y Chandramohan, Y.: «Epigenetic me-chanisms in stress-related memory formation», Psycho-neuroendocrinology, vol. 32, suplemento del 1 de agostode 2007 (publicación electrónica: 17 de julio de 2007),pp. S21-S25.

57. Hitchins, M. P. y R. L. Ward: «Constitutional(germline) MLH1 epimutation as an aetiological mecha-nism for hereditary non-polyposis colorectal cancer», Jour-nal of Medical Genetics, vol. 46, 2009, pp. 793-802.

58. Huang J., C. Plass y C. Gerhäuser: «Cancer Che-moprevention by Targeting the Epigenome», CurrentDrug Targets, 15 de diciembre de 2010.

59. Tolle, Eckhart. A New Earth: Awakening to YourLife’s Purpose, Plume, 2006.

60. Handel, A. E. y S. V. Ramagopalan: «Is Lamarc-kian evolution relevant to medicine?», BMC Medical Ge-netics, vol. 11, 13 de mayo de 2010, p. 73.

6. Tú, yo y el universo


2. Braden, Gregg: The Divine Matrix, California, HayHouse, 2007.

3. Ventegodt, S., T. D. Hermansen, T. Flensborg-Madsen et al.:«Human development VII: A spiral fractalmodel of fine structure of physical energy could explain


22

central aspects of biological information, biological organi-zation and biological creativity», The Scientific World Jour-nal, vol. 6, 14 de noviembre de 2006, pp. 1434-1440.

4. McTaggart, Lynne: The Field, New York, HarperPerennial, 2002.

5. Church, Dawson: The Genie in your Genes, Cali-fornia, Energy Psychology Press, 2008.

6. Beauregard, Mario Y Denyse O’Leary: Du cerveauà Dieu, París, Guy Trédaniel Éditeur, 2008.

7. Turk, D. J., T. F. Heatherton, W. M. Kelley et al.:«Mike or me? Selfrecognition in a split-brain patient»,Nature Neuroscience, vol. 5, nº 9, septiembre de 2002,pp. 841-842.

8. Turk, D. J., T. F. Heatherton, C. N. Macrae et al.:«Out of contact, out of mind: The distributed nature of theself», Ann NY Acad Sci, vol. 1001, octubre de 2003, pp. 65-78.

9. Taylor, Jill Bolte: My stroke of insight: A brainscientist’s personal journey, New York, Viking PenguinGroup, 2006.

10. Tinnin, L: «The anatomy of the ego», Psychiatry,vol. 52, nº 4, noviembre de 1989, pp. 404-409.

11. Miller, L.: «Brain and self: Toward a neuropsy-chodynamic model of ego autonomy and personality»,Journal of the American Academy of Psychoanalysis,vol. 19, nº 2, verano de 1991, pp. 213-234.

12. Joseph, R.: «The neuropsychology of developmenthemispheric laterality, limbic language, and the origin ofthought», Journal of Clinical Psychology, vol. 38, nº 1, ene-ro de 1982, pp. 4-33.

13. Becker, Robert y Gary Selden: The Body Electric,New York, Harper, 1985.

14. Tolle, Eckhart: The power of now, Vancouver, Na-maste, 1997. [Hay edición española: El poder del ahora,Madrid, Gaia, 2001.]

15. Tolle, Eckhart: A new Earth, New York, Plume,2005. [Hay edición española: Un mundo nuevo ahora, Bar-celona, Debolsillo, 2008.]

16. Andersen, U. S.: Three Magic Words, California,Wilshire Book Co., 1954.


23

7. El equilibrio de la salud

1. Robitaille Manouvrier, Johanne: Notre pouvoir deguérison, Montreal, Libre Expression, 2005.

2. Armstrong, Lance: It’s Not About the Bike: MyJourney Back to Life, Berkley, 2000.

3. Corneau, Guy: Revivre, Montreal, Les Éditions del’Homme, 2010.

4. Simonton, Carl: L’aventure d’une guérison, Bel-fond, 1993. [Hay edición española: Recuperar la salud: unaapuesta por la vida, Madrid, Los libros del comienzo, 1998].

5. Pelusi, J.: «The lived experience of surviving breastcancer», ONF, vol. 24, nº 8, septiembre de 1997, pp. 1343-1353.

6. Perreault, A. y F. F. Bourbonnais: «The experienceof suffering as lived by women with breast cancer», Inter-national Journal of Palliative Nursing (Int J Palliat Nurs),vol. 11, nº 10, octubre de 2005, pp. 510, 512-519.

7. Gawler, Ian: You Can Conquer Cancer: Preven-tion and management, Melbourne, Hill of Content, 2001.

8. Meares, A.: «Regression of osteogenic sarcomametastases associated with intensive meditation», MedicalJournal of Australia, vol. 2, nº 9, 21 de octubre de 1978,p. 433.

9. Bacci, G., E. Palmerini, E. L. Staals et al.: «Sponta-neous regression of lung metastasis from osteosarcoma:A case report», Journal of Pediatric Hematology/Oncology,vol. 30, nº 1, enero de 2008, pp. 90-92.

10. Serban-Shreiber, David: Anticancer, París, Édi-tions Robert Laffont, 2007.

8. La salud emocional

1. http://www.stress.org/2. Danziger, Nicolas, Faillenot, Isabelle y Peyron, Ro-

land: «Can We Share a Pain We Never Felt? Neural Correla-tes of Empathy in Patients with Congenital Insensitivity toPain», Neuron, vol. 61, nº 2, 29 de enero de 2009, pp. 203-212.


24


4. Banyan, Calvin D.:The Secret Language of Fe-elings: A Rational Approach to Emotional Mastery, BanyanHypnosis Center, 2002.

5. Radin, D. I.: «Gut Feelings, Intuition, and Emo-tions: An Exploratory Study», The Journal of Alternativeand Complementary Medicine, vol. 11, nº 1, 2005, pp. 85-91.

6. Giese-Davis, J., K. Collie, K. M. Rancourt et al.:«Decrease in depression symptoms is associated with lon-ger survival in patients with metastatic breast cancer: asecondary analysis», Journal of Clinical Oncology (J ClinOncol), vol. 29, nº 4, 1 de febrero de 2011 (publicación elec-trónica: 3 de diciembre de 2010), pp. 413-420.

7. Oh, E. S., Y. K. Seo y H. H. Yoon: «Effects of sub-sonic vibration on the proliferation and maturation of 3T3-L1 cells», Life Sciences, vol. 88, nº 3-4, 17 de enero de 2011,pp. 169-177.

8. Adair, R. K.: «Vibrational resonances in biologicalsystems at microwave frequencies», Biophysical Journal,vol. 82, nº 3, marzo de 2002, pp. 1147-1152.

9. Wachi, M. et al.: «Recreational music-making mo-dulates natural killer cell activity, cytokines, and mood sta-tes in corporate employees», Medical Science Monitor,vol. 13, nº 2, febrero de 2007, pp. CR57-CR70.

10. Rein, Glen: «Biological Effects of Scalar AcousticEnergy: modulation of DNA», Proc. US PsychotronicsAssoc., Columbus, Ohio, julio de 1998.

11. McCraty, Rollin, Mike Atkinson, Glen Rein et al.:«Music Enhances the Effect of Positive Emotional States onSalivary IgA», Stress Medicine, vol. 12, nº 3, pp. 167-175.

12. McCraty, Rollin, Bob Barrios-Choplin, Mike At-kinson et al.: «The Effects of Different Types of Music onMood, Tension, and Mental Clarity», Alternative Thera-pies in Health and Medicine, vol. 4, nº 1, 1998, pp. 75-84.

13. Werner, Kenny: Effortless Mastery: Liberating themaster musician within, Jamey Aebersold, 1996.

14. Creath, K. y G. E. Schwartz: «Measuring effects ofmusic, noise, and healing energy using a seed germination


25

bioassay», Journal of Alternative and Complementary Me-dicine, vol. 10, nº 1, febrero de 2004, pp. 113-122.

15. Laccetti, M.: «Expressive writing in women withadvanced breast cancer», ONF, vol. 34, nº 5, septiembre de2007, pp. 1019-1024.

16. Monti, D. A., C. Peterson, E. J. Kunkel et al.: «Arandomized, controlled trial of mindfulness-based art the-rapy (MBAT) for women with cancer», Psycho-Oncology,vol. 15, nº 5, mayo de 2006, pp. 363-373.

17. Svensk, A. C., I. Oster, K. E. Thyme et al.: «Arttherapy improves experienced quality of life among wo-men undergoing treatment for breast cancer: A randomizedcontrolled study», European Journal of Cancer Care(Engl), vol. 18, nº 1, enero de 2009, pp. 69-77.

18. Bar-Sela, G., L. Atid, S. Danos et al.: «Art therapyimproved depression and influenced fatigue levels in cancerpatients on chemotherapy», Psycho-Oncology, vol. 16, nº 11,noviembre de 2007, pp. 980-984.

19. Nainis, N., J. A. Paice, J. Ratner et al.: «Relievingsymptoms in cancer: Innovative use of art therapy», Jour-nal of Pain and Symptom Management, vol. 31, nº 2, febre-ro de 2006, pp. 162-169.

20. Oster, I., A. C. Svensk, E. Magnusson et al.: «Arttherapy improves coping resources: A randomized, con-trolled study among women with breast cancer», Palliativeand Supportive Care, vol. 4, nº 1, marzo de 2006, pp. 57-64.

21. Petterson, M.: «Music for healing: The creative artsprogram at the Ireland Cancer Center», Alternative Thera-pies in Health and Medicine, vol. 7, nº 1, enero de 2001,pp. 88-89.

22. Elkins, G., W. Fisher y A. Johnson: «Mind-bodytherapies in integrative oncology», Current Treatment Op-tions in Oncology, vol. 11, nº 3-4, diciembre de 2010,pp. 128-140.

23. Hilliard, R. E.: «The effects of music therapy onthe quality and length of life of people diagnosed with ter-minal cancer», Journal of Music Therapy, vol. 40, nº 2, vera-no de 2003, pp. 113-137.

24. Morgan, N. P., K. D. Graves, E. A. Poggi et al.: «Im-


26

plementing an expressive writing study in a cancer clinic»,The Oncologist, vol. 13, nº 2, febrero de 2008, pp. 196-204.

25. Feldman, Robert: Introduction à la psychologie.Approches contemporaines, Chenelière/McGraw-Hill, 1993.

26. Bennett, M. P., J. M. Zeller, L. Rosenberg et al.:«The effect of mirthful laughter on stress and natural killercell activity», Alternative Therapies in Health and Medici-ne, vol. 9, nº 2, marzo y abril de 2003, pp. 38-45.

27. Hayashi, T. y K. Murakami: «The effects oflaughter on post-prandial glucose levels and gene expres-sion in type 2 diabetic patients», Life Sciences, vol. 85,nº 5-6, 31 de julio de 2009 (publicación electrónica: 18 demayo de 2009), pp. 185-187.

28. http://www.patchadams.org/29. Church, Dawson: The Genie in your Genes, Cali-

fornia, Energy Psychology Press, 2008.30. Grinberg-Zylberbaum, J. y J. Ramos: «Patterns of

interhemispheric correlation during human communica-tion», International Journal of Neuroscience (Int J Neuro-sci), vol. 36, nº 1-2, septiembre de 1987, pp. 41-53.

31. Press, C., J. Cook, S. J. Blakemore et al.: «Dynamicmodulation of human motor activity when observing ac-tions», J Neurosci, vol. 31, nº 8, 23 de febrero de 2011,pp. 2792-2800.

32. Uithol, S., I. Van Rooij, H. Bekkering, H. et al.:«Understanding motor resonance», Society for Neuroscien-ce, 4 de marzo de 2011, pp. 1-10.

33. Csikszentmihalyi, Mihaly: Flow, New York, Har-per Perennial, 1991.

34. Williams, J. B., D. Pang, B. Delgado et al.: «A mo-del of gene-environment interaction reveals altered mam-mary gland gene expression and increased tumor growthfollowing social isolation», Cancer Prevention Research,vol. 2, nº 10, octubre de 2009 (publicación electrónica: 29 deseptiembre de 2009), pp. 850-861.

35. Cole, S. W. et al.: «Social regulation of gene expres-sion in human leukocytes», Genome Biology, vol. 8, 2007,p. R189.

36. Antoni, M. H.: «The influence of bio-behavioural


27

factors on tumour biology: Pathways and mechanisms»,Nature Reviews Cancer, vol. 6, nº 3, 2006, pp. 240-248.

37. Lutgendorf, S. K., K. Degeest, L. Dahmoush et al.:«Social isolation is associated with elevated tumor norepi-nephrine in ovarian carcinoma patients», Brain Behav Im-mun, vol. 25, nº 2, febrero de 2011 (publicación electrónica:16 de octubre de 2010), pp. 250-255.

38. Fontaine, J. R., K. R. Scherer, E. B. Roesch et al.:«The world of emotions is not two-dimensional», Psycho-logical Science, vol. 18, nº 12, diciembre de 2007, pp. 1050-1057.

39. Beck, A. Cognitive Therapy and the EmotionalDisorders, New York, International Universities Press,1976.

40. Park, Na-Jin et al.: «Breast cancer risk and immuneresponse in healthy women», ONF, vol. 33, nº 6, 2006,pp. 1151-1159.


42. Schnur, J. B., I. Kafer, C. Marcus et al.: «Hypnosisto manage distress related to medical procedures: A meta-analysis», Contemporary Hypnosis, vol. 25, nº 3-4, 21 deagosto de 2008, pp. 114-128.

43. Sohl, S. J., L. Stossel, J. B. Schnur et al.: «Intentionsto use hypnosis to control the side effects of cancer and itstreatment», Am J Clin Hypn, vol. 53, nº 2, octubre de 2010,pp. 93-100.

44. Néron, S. et al.: «Effectiveness of hypnotherapywith cancer patients’ trajectory: Emesis, acute pain, andanalgesia and anxiolysis in procedures», International Jour-nal of Clinical and Experimental Hypnosis, vol. 55, nº 3,2007, pp. 336-354.

45. Flory, N. et al.: «Practical Hypnotic interventionsduring invasive cancer diagnosis and treatment», Hemato-logy/Oncology Clinics of North America, vol. 22, nº 4,agosto de 2008, pp. 709-725.

46. Montgomery, G. H., D. H. Bovbjerg, J. B. Schnuret al.: «A randomized clinical trial of a brief hypnosis in-tervention to control side effects in breast surgery pa-


28

tients», JNCI, vol. 99, nº 17, 5 de septiembre de 2007 (pu-blicación electrónica: 28 de agosto de 2007), pp. 1304-1312.

47. Hall, H.: «Healing mysteries: An interview withHoward Hall, PhD, PsyD», Advances in Mind-Body Me-dicine, vol. 22, nº 1, verano de 2007, pp. 28-31. Entrevistacon Sheldon Lewis.

48. Becker, Robert y Gary Selden: The Body Electric,New York, Harper, 1985.

49. Vandevusse, L., L. Hanson, M. A. Berner et al.:«Impact of self-hypnosis in women on select physiologicand psychological parameters», Journal of Obstetric, Gyne-cologic, & Neonatal Nursing, vol. 39, nº 2, marzo de 2010,pp. 159-168.

50. Halley, F. M.: «Self-regulation of the immune sys-tem through biobehavioral strategies», Biofeedback andSelf-Regulation, vol. 16, nº 1, marzo de 1991, pp. 55-74.

51. Kovács Z. A., L. G. Puskás, A. Juhász et al.: «Hyp-nosis upregulates the expression of immune-related genesin lymphocytes», Psychotherapy and Psychosomatics,vol. 77, nº 4, 2008 (publicación electrónica: 25 de abril de2008), pp. 257-259.

52. Schnur, Julie B.: «A randomized trial of a cogniti-ve-behavioral therapy and hypnosis intervention on positi-ve and negative affect during breast cancer Radiotherapy»,Journal of Clinical Psychology, vol. 65, nº 4, abril de 2009,pp. 443-455.

53. Liberman, Jacob: Light: Medicine of the Future,New Mexico, Bear and Co., 1991.

54. De Craen, A. J. M., P. J. Roos, A. L. de Vries et al.:«Effect of colour of drugs: Systematic review of perceivedeffect of drugs and of their effectiveness», British MedicalJournal, vol. 313, 1996, pp. 1624-1626.

55. Virk, G., G. Reeves, N. E. Rosenthal et al.: «Shortexposure to light treatment improves depression scores inpatients with seasonal affective disorder: A brief report»,International Journal on Disability and Humand Develop-ment (Int J Disabil Hum Dev), vol. 8, nº 3, julio de 2009,pp. 283-286.


29

9. La salud espiritual

1. Ramondetta, L. M. y D. Sills: «Spirituality in gyne-cological oncology: A review», International Journal ofGynecological Cancer (Int J Gynecol Cancer), vol. 14, nº 2,marzo-abril de 2004, pp. 183-201.


3. Perreault, A. y F. F. Bourbonnais: «The experienceof suffering as lived by women with breast cancer», Int J Pa-lliat Nurs, vol. 11, nº 10, octubre de 2005, pp. 510, 512-519.

4. Breitbart, W.: «Spirituality and meaning in suppor-tive care: spirituality -and meaning- centered group psy-chotherapy interventions in advanced cancer», SupportiveCare in Cancer, vol. 10, nº 4, mayo de 2002 (publicaciónelectrónica: 28 de agosto de 2001), pp. 272-280.

5. Ando, M.: «The efficacy of mindfulness-based me-ditation therapy on anxiety, depression, and spirituality inJapanese patients with cancer», Journal of Palliative Medi-cine (J Palliat Med), vol. 12, nº 12, 2009, pp. 1091-1094.

6. Yang, W., T. Staps y E. Hijmans: «Existential crisisand the awareness of dying: The role of meaning and spiri-tuality», Omega, vol. 61, nº 1, 2010, pp. 53-69.

7. Berger, Ann: Principles and practises of palliativecare and supportive oncology, Filadelfia, Lippincott Wi-lliams & Wilkins, 2007.

8. Sinclair, S., M. Mysak y N. A. Hagen: «What arethe core elements of oncology spiritual care programs?»,Palliative & Supportive Care, vol. 7, nº 4, de diciembre de2009, pp. 415-422.

9. Moseley, J. B., K. O’Malley, N. J. Petersen et al.:«A controlled trial of arthroscopic surgery for osteoarthri-tis of the knee», NEJM, vol. 347, nº 2, 11 de julio de 2002,pp. 81-88.

10. Simonton, O. C.: Getting Well Again, Los Angeles,Tarcher, 1978.

11. Boureau, F., A. Leizorovicz y F. Caulin: «The pla-cebo effect in bone metastatic pain», La Presse Médicale,vol. 17, nº 21, 28 de mayo de 1988, pp. 1063-1066.


30

12. Lipton, Bruce: The Biology of Belief, New York,Hay House, 2005.

13. Garud, S., A. Brown, A. Cheifetz et al.: «Meta-analysis of the placebo response in ulcerative colitis», Diges-tive Diseases and Sciences, vol. 53, nº 4, abril de 2008 (publi-cación electrónica: 13 de octubre de 2007), pp. 875-891.

14. Su, C., J. D. Lewis, B. Goldberg et al.: «A meta-analysis of the placebo rates of remission and response inclinical trials of active ulcerative colitis», Gastroenterology,vol. 132, nº 2, febrero de 2007 (publicación electrónica:20 de diciembre de 2006), pp. 516-526.

15. Weihrauch, T. R. y T. C. Gauler: «Placebo-effica-cy and adverse effects in controlled clinical trials», Arz-neimittel-Forschung, vol. 49, nº 5, mayo de 1999, pp. 385-393.

16. Kirsch, Irving: «The Emperor’s New Drugs: AnAnalysis of Antidepressant Medication Data Submittedto the U.S. Food and Drug Administration», Prevention& Treatment, vol. 5, nº 23, 15 de julio de 2002.

17. Waring, D. R.: «The antidepressant debate and thebalanced placebo trial design: An ethical analysis», Interna-tional Journal of Law and Psychiatry, vol. 31, nº 6, diciembrede 2008 (publicación electrónica: 26 de octubre de 2008),pp. 453-462.

18. De Craen, A. J. M., P. J. Roos, A. L. de Vries et al.:«Effect of colour of drugs: Systematic review of perceivedeffect of drugs and of their effectiveness», British MedicalJournal, vol. 313, 1996, pp. 1624-1626.

19. Park, Na-Jin et al.: «Breast cancer risk and immu-ne response in healthy women», ONF, vol. 33, nº 6, 2006,pp. 1151-1159.

20. Rubman, S., A. J. Goreczny, P. J. Brantley et al.:«Pseudocyesis and depression: Etiological and treatmentconsiderations», Journal of the Lousiana State Medical So-ciety, vol. 141, nº 11, noviembre de 1989, pp. 39-41.

21. Hendricks-Matthews, Marybeth K. y Douglas M.Hoy: «Pseudocyesis in an Adolescent Incest Survivor»,Journal of Family Practice, vol. 36, nº 1, enero de 1993,pp. 97-104.


31

22. O’Grady, J. y M. Rosenthal: «Pseudocyesis: A mo-dern perspective on an old disorder», Obstetrical & Gyne-cological Survey, vol. 44, 1989, pp. 500-511.

23. Csikszentmihalyi, Mihaly: Flow, New York, Har-per Perennial, 1991.

24. Donaldson, V. W.: «A clinical study of visualiza-tion on depressed white blood cell count in medical pa-tients», Applied Psychophysiology and Biofeedback, vol. 25,nº 2, junio de 2000, pp. 117-128.

25. Gruzelier, J. H.: «A review of the impact of hypno-sis, relaxation, guided imagery and individual differenceson aspects of immunity and health», Stress, vol. 5, nº 2, ju-nio de 2002, pp. 147-163.

26. Lerner, M.: Choices in Healing, Cambridge, TheMIT Press, 1996.

27. Tolle, Eckhart: The power of now, Vancouver, Na-maste Publishing, 1997 [Hay edición española: El poder delahora, Madrid, Gaia, 2001.].


29. Beck, Robert C.: «Mood modification with ELFmagnetic fields: A preliminary exploration», Archaeus,vol. 4, 1986.

30. Lipton, Bruce H.: The Biology of Belief [audioli-bro], Sounds True, Incorporated, 2006.

31. Trojak, B., J. C. Chauvet-Gelinier, B. Vergès et al.:«Significant increase in plasma thyroid-stimulating hor-mone during low-frequency repetitive transcranial magne-tic stimulation», The Journal of Neuropsychiatry and Clini-cal Neurosciences, vol. 23, nº 1, otoño de 2011, p. E12.

32. Hodgson, B. D., B. Pyszka, M. M. Henry et al.:«Effect of Photobiomodulation on Vinblastine-PoisonedMurine HERS Cells», Photomedicine and Laser Surgery,vol. 29, nº 4, abril de 2011 (publicación electrónica: 23 dediciembre de 2010), pp. 233-237.

33. Hallberg, O. y O. Johansson: «Melanoma inciden-ce and frequency modulation (FM) broadcasting», Archi-ves of Environmental Health, vol. 57, nº 1, enero-febrerode 2002, pp. 32-40.


32

34. Mochizuki-Oda, N., Y. Kataoka, Y. Cui et al.:«Effects of near-infra-red laser irradiation on adenosine tri-phosphate and adenosine diphosphate contents of rat braintissue», Neuroscience Letters, vol. 323, nº 3, 3 de mayo de2002, pp. 207-210.

35. European Environment Agency: «BioInitiativeReport», informe de 2007. En http://www.bioinitiative.org/report/index.htm

36. Li, Q., K. Morimoto, M. Kobayashi et al.: «Visi-ting a forest, but not a city, increases human natural killeractivity and expression of anticancer proteins», Interna-tional Journal of Immunopathology and Pharmacology,vol. 21, nº 1, enero-marzo de 2008, pp. 117-127.

37. Li, Q., K. Morimoto, A. Nakadai et al.: «Forest ba-thing enhances human natural killer activity and expressionof anti-cancer proteins», International Journal of Immuno-pathology and Pharmacology, vol. 20, nº 2, suplemento 2,abril-junio de 2007, pp. 3-8.

38. Li, Q., M. Kobayashi, H. Inagaki et al.: «A day tripto a forest park increases human natural killer activity andthe expression of anti-cancer proteins in male subjects»,Journal of Biological Regulators and Homeostatic Agents,vol. 24, nº 2, abril-junio de 2010, pp. 157-165.

39. Elkins, G., W. Fisher y A. Johnson: «Mind-bodytherapies in integrative oncology», Current Treatment Op-tions in Oncology, vol. 11, nº 3-4, diciembre de 2010,pp. 128-140.

40. Carlson, L. E. et al.: «One-year pre-post inter-vention follow-up of psychological, immune, endocrineand blood pressure outcomes of mindfulness-based stressreduction (MBSR) in breast and prostate cancer outpa-tients», Brain Behav Immun, vol. 21, nº 8, 2007, pp. 1038-1049.

41. Carlson, L. E., M. Speca, K. D. Patel et al.: «Mind-fulness-based stress reduction in relation to quality of life,mood, symptoms of stress and levels of cortisol, dehydro-epiandrosterone sulfate (DHEAS) and melatonin in breastand prostate cancer outpatients», Psychoneuroendocrino-logy, vol. 29, nº 4, mayo de 2004, pp. 448-474.


33

42. Witek-Janusek, L. et al.: «Effect of mindfulness ba-sed stress reduction on immune function, quality of life andcoping in women newly diagnosed with early breast can-cer», Brain Behav Immun, vol. 22, nº 6, agosto de 2008,pp. 969-981.

43. Matchim, Y.: «Measuring the psychological impactof mindfulness meditation on health among patients withcancer: A literature review», ONF, vol. 34, nº 5, 2007,pp. 1059-1066.

44. Coker, K.: «Meditation and prostate cancer: Inte-grating a mind/body intervention with traditional thera-pies», Seminars in Urologic Oncology, vol. 17, nº 2, 1999,pp. 111-118.

45. Ando, M.: «The efficacy of mindfulness-based me-ditation therapy on anxiety, depression, and spirituality inJapanese patients with cancer», J Palliat Med, vol. 12, nº 12,2009, pp. 1091-1094.

46. Zeidan, F., S. K. Johnson, B. J. Diamond et al.:«Mindfulness meditation improves cognition: Evidence ofbrief mental training», Consciousness and Cognition,vol. 19, nº 2, junio de 2010 (publicación electrónica: 3 deabril de 2010), pp. 597-605.

47. Davidson, R. J., J. Kabat-Zinn, J. Schumacher etal.: «Alterations in brain and immune function producedby mindfulness meditation», Psychosom Med, vol. 65, nº 4,julio-agosto de 2003, pp. 564-570.

48. Rossi, E. et al.: «A pilot study of positive expecta-tions and focused attention via a new protocol for optimi-sions therapeutic hypnosis and psychotherapy and assessedwith DNA Microarrays: The creative psychosocial Geno-mic Healing experience», Sleep and Hypnosis, vol. 10, nº 2,2008, pp. 39-44.

49. Meares, A.: «Regression of osteogenic sarcomametastases associated with intensive meditation», MedicalJournal of Australia, vol. 2, nº 9, 21 de octubre de 1978,p. 433.

50. Gawler, Ian: You Can Conquer Cancer: Preven-tion and Management, Melbourne, Hill of Content, 2001.

51. Feldman, Robert: Introduction à la psychologie.


34

Approches contemporaines, Montreal, Chenelière/McGraw-Hill, 1993.


53. Mctaggart, Lynne: The Field, New York, HarperPerennial, 2002.

54. Tolle, Eckhart: A New Earth, New York, Plume,2005. [Hay edición española: Un mundo nuevo ahora, Bar-celona, Debolsillo, 2008.]


56. Beauregard, Mario y Denyse O’Leary: Du cerveauà Dieu, París, Guy Trédaniel Éditeur, 2008.

57. Artaud, Gérard: Se connaître soi-même. La crised’identité de l’adulte, Montreal, Les Éditions de l’Homme,1978.

58. Nelson, C., C. M. Jacobson, M. I. Weinberger etal.: «The role of spirituality in the relationship between re-ligiosity and depression in prostate cancer patients», An-nals of Behavioral Medicine, vol. 38, nº 2, octubre de 2009,pp. 105-114.

59. Chandwani, K. D., B. Thornton, G. H. Perkins etal.: «Yoga improves quality of life and benefit finding inwomen undergoing radiotherapy for breast cancer», Jour-nal of the Society for Integrative Oncology (J Soc IntegrOncol), vol. 8, nº 2, primavera de 2010, pp. 43-55.

60. Danhauer, S. C., J. A. Tooze, D. F. Farmer et al.:«Restorative yoga for women with ovarian or breast can-cer: Findings from a pilot study», Journal of the Society forIntegrative Oncology (J Soc Integr Oncol), vol. 6, nº 2, pri-mavera de 2008, pp. 47-58.

61. Shannahoff-Khalsa, D. S.: «Patient perspectives:Kundalini Yoga meditation techniques for psycho-oncolo-gy and as a potential therapies for cancer», Integr CancerTher, vol. 4, nº 1, 2005, pp. 87-100.

62. Bensoussan, S.: Mieux vivre avec le cancer, Mon-treal, Les Éditions de l’Homme, 2009.


35

10. La salud psíquica y otras herramientas

1. Maio, G., S. Saraeb y A. Marchiori: «Physical activi-ty and PDE5 inhibitors in the treatment of erectile dys-function: Results of a randomized controlled study», TheJournal of Sexual Medicine, vol. 7, nº 6, junio de 2010 (pu-blicación electrónica: 30 de marzo de 2010), pp. 2201-2208.

2. Hafner-Holter, S., M. Kopp y V. Günther: «Effectsof fitness training and yoga on well-being stress, socialcompetence and body image», Neuropsychiatrie KlinikDiagnostik Therapie und Rehabilitation Organ der Ge-sellschaft Osterreichischer Nervenarzte und Psychiater,vol. 23, nº 4, 2009, pp. 244-248.

3. Barbaric, M., E. Brooks, L. Moore et al.: «Effects ofphysical activity on cancer survival: A systematic review»,Physiotherapy Canada, vol. 62, nº 1, invierno de 2010 (pu-blicación electrónica: 22 de febrero de 2010), pp. 25-34.

4. Friedenreich, C. M., H. K. Neilson y B. M. Lynch:«State of the epidemiological evidence on physical activityand cancer prevention», Eur J Cancer, vol. 46, nº 14, sep-tiembre de 2010, pp. 2593-2604.

5. Tehard, B., C. M. Friedenreich, J. M. Oppert et al.:«Effect of physical activity on women at increased risk ofbreast cancer: Results from the E3N cohort study», CancerEpidemiology, Biomarkers & Prevention, vol. 15, nº 1, ene-ro de 2006, pp. 57-64.

6. Kenfield, S. A., M. J. Stampfer, E. Giovannucci etal.: «Physical activity and survival after prostate cancerdiagnosis in the health professionals follow-up study», JClin Oncol, vol. 29, nº 6, 20 de febrero de 2011 (publicaciónelectrónica: 4 de enero de 2011), pp. 726-732.

7. Almeida, P. W., A. Gomes-Filho, A. J. Ferreira etal.: «Swim training suppresses tumor growth in mice», Jour-nal of Applied Physiology, vol. 107, nº 1, julio de 2009 (pu-blicación electrónica: 28 de mayo de 2009), pp. 261-265.

8. Collins, A., L. E. Hill, Y. Chandramohan et al.:«Exercise improves cognitive responses to psychologicalstress through enhancement of epigenetic mechanisms andgene expression in the dentate gyrus», PLoS One, vol. 4,


36

nº 1, 2009 (publicación electrónica: 30 de enero de 2009),p. e4330.

9. Shephard, R. J., T. J. Verde, S. G. Thomas et al.:«Physical activity and the immune system», Canadian Jour-nal of Applied Sport Sciences, vol. 16, nº 3, septiembre de1991, pp. 169-185.

10. Shephard, R. J., S. Rhind y P. N. Shek: «Exerciseand the immune system: Natural killer cells, interleukins andrelated responses», Sports Medicine, vol. 18, nº 4, noviem-bre de 1994, pp. 340-369.

11. Wang, J., H. Song, X. Tang et al.: «Effect of exerci-se training intensity on murine T-regulatory cells and vac-cination response», Scandinavian Journal of Medicine &Science in Sports, vol. 22 nº 5, octubre de 2012 (publicaciónelectrónica: 16 de marzo de 2011), pp. 643-652 (publicaciónelectrónica: 16 de marzo de 2011).


13. Liberman, Jacob: Light: Medicine of the Future,New Mexico, Bear and Co., 1991.

14. Mitchell, D. L., A. A. Fernandez, R. S. Nairn etal.: «Ultraviolet A does not induce melanomas in a Xipho-phorus hybrid fish model», Proceedings of the NationalAcademy of Science of the USA, vol. 107, nº 20, 18 de mayode 2010 (publicación electrónica: 3 de mayo de 2010),pp. 9329-9334.

15. Watson, A.: «Photochemotherapy for mycosisfungoides: Current status», Australasian Journal of Derma-tology, vol. 38, nº 1, febrero de 1997, pp. 9-11.

16. Oh, E. Y., C. Ansell, H. Nawaz et al.: «Globalbreast cancer seasonality», Breast Cancer Research andTreatment, vol. 123, nº 1, agosto de 2010 (publicación elec-trónica: 4 de febrero de 2010), pp. 233-243.

17. Tuohimaa, P., E. Pukkala y G. Scélo: «Does solarexposure, as indicated by the non-melanoma skin cancers,protect from solid cancers: Vitamin D as a possible expla-nation», Eur J Cancer, vol. 43, nº 11, julio de 2007 (publica-ción electrónica: 30 de mayo de 2007), pp. 1701-1712.

18. Kricker, A. y B. Armstrong: «Does sunlight have a


37

beneficial influence on certain cancers?», Progress in Bio-physics and Molecula Biology, vol. 92, nº 1, septiembre de2006 (publicación electrónica: 28 de febrero de 2006),pp. 132-139.

19. Porojnicu, A. C., T. E. Robsahm, A. Dahlback etal.: «Seasonal and geographical variations in lung cancerprognosis in Norway: Does Vitamin D from the sun play arole?», Lung Cancer, vol. 55, nº 3, marzo de 2007 (publica-ción electrónica: 17 de enero de 2007), pp. 263-270.

20. Porojnicu, A. C., A. Dahlback y J. Moan: «Sun ex-posure and cancer survival in Norway: Changes in the riskof death with season of diagnosis and latitude», Advancesin Experimental Medicine and Biology, vol. 624, 2008,pp. 43-54.

21. Ainsleigh, H. G.: «Beneficial effects of sun exposu-re on cancer mortality», Preventive Medicine (Prev Med),vol. 22, nº 1, enero de 1993, pp. 132-140.

22. Grant, W. B.: «Good evidence exists that solar ul-traviolet-B and vitamin D reduce the risk of ovarian can-cer», American Journal of Obstetrics & Gynecology,vol. 203, nº 5, noviembre de 2010 (publicación electrónica:3 junio de 2010), p. e10; respuesta del autor pp. e10-e11.

23. Grant, W. B.: «An estimate of premature cancermortality in the U.S. due to inadequate doses of solar ultra-violet-B radiation», Cancer, vol. 94, nº 6, 15 de marzo de2002, pp. 1867-1875.

24. Apperly, F. L.: «The relation of solar radiation tocancer mortality in North America», Cancer Research,vol. 1, pp. 191-195.

25. Boscoe, F. P. y M. J. Schymura: «Solar ultraviolet-Bexposure and cancer incidence and mortality in the UnitedStates, 1993-2002», BMC Cancer, vol. 6, 10 de noviembrede 2006, p. 264.

26. Mohr, S. B., C. F. Garland, E. D. Gorham et al.:«Ultraviolet B irradiance and vitamin D status are inverselyassociated with incidence rates of pancreatic cancer world-wide», Pancreas, vol. 39, nº 5, julio de 2010, pp. 669-674.

27. Mohr, S. B., C. F. Garland, E. D. Gorham et al.:«Relationship between low ultraviolet B irradiance and


38

higher breast cancer risk in 107 countries», Breast Journal,vol. 14, nº 3, mayo-junio de 2008 (publicación electrónica:17 de abril de 2008), pp. 255-260.

28. Osborne, J. E. y P. E. Hutchinson: «Vitamin D andsystemic cancer: Is this relevant to malignant melanoma?»,British Journal of Dermatology, vol. 147, nº 2, agosto de2002, pp. 197-213.

29. Krishnan, A. V., D. M. Peehl y D. Feldman: «Therole of vitamin D in prostate cancer», Recent Results inCancer Research, vol. 164, 2003, pp. 205-221.

30. Toriola, A. T., H. M. Surcel, A. Calypse et al.: «Inde-pendent and joint effects of serum 25-hydroxyvitamin D andcalcium on ovarian cancer risk: A prospective nested case-control study», Eur J Cancer, vol. 46, nº 15, octubre de 2010(publicación electrónica: 18 de junio de 2010), pp. 2799-2805.

31. Ooi, L. L., Y. Zheng, H. Zhou et al.: «Vitamin Ddeficiency promotes growth of MCF-7 human breast can-cer in a rodent model of osteosclerotic bone metastasis»,Bone, vol. 47, nº 4, octubre de 2010 (publicación electróni-ca: 16 de julio de 2010), pp. 795-803.

32. Mezawa, H. y Sugiura T.: «Serum vitamin D levelsand survival of patients with colorectal cancer: Post-hocanalysis of a prospective cohort study», BMC Cancer,vol. 10, 2 de julio de 2010, p. 347.

33. Goodwin, P. J., M. Ennis, K. I. Pritchard et al.:«Prognostic effects of 25-hydroxyvitamin D levels in earlybreast cancer24», J Clin Oncol, vol. 27, nº 23, 10 de agos-to de 2009 (publicación electrónica: 18 de mayo de 2009),pp. 3757-3763.

34. Spina, C., V. Tangpricha, M. Yao et al.: «Coloncancer and solar ultraviolet B radiation and prevention andtreatment of colon cancer in mice with vitamin D and itsGemini analogs», The Journal of Steroid Biochemistry andMolecular Biology, vol. 97, nº 1-2, octubre de 2005 (publi-cación electrónica: 8 de septiembre de 2005), pp. 111-120.

35. Giovannucci, E.: «The epidemiology of vitamin Dand cancer incidence and mortality: A review (United Sta-tes)», Cancer Causes & Control, vol. 16, nº 2, marzo de2005, pp. 83-95.


39

36. Padillo, F. J., J. F. Ruiz-Rabelo, A. Cruz et al.: «Me-latonin and celecoxib improve the outcomes in hamsterswith experimental pancreatic cancer», Journal of Pineal Re-search (J Pineal Res), vol. 49, nº 3, octubre de 2010, pp. 64-70.

37. Mao, L., Q. Cheng, B. Guardiola-Lemaître et al.:«In vitro and in vivo antitumor activity of melatonin recep-tor agonists», J Pineal Res, vol. 49, nº 3, octubre de 2010,pp. 210-221.

38. Sánchez-Barceló, E. J., S. Cos, R. Fernández et al.:«Melatonin and mammary cancer: A short review», Endocri-ne-Related Cancer, vol. 10, nº 2, junio de 2003, pp. 153-159.

39. Cos, S. y E. J. Sánchez-Barceló: «Melatonin, expe-rimental basis for a possible application in breast cancerprevention and treatment», Histology & Histopathology,vol. 15, nº 2, abril de 2000, pp. 637-647.

40. Blask, D. E.: «Melatonin, sleep disturbance andcancer risk», Sleep Medicine Reviews, vol. 13, nº 4, agostode 2009 (publicación electrónica: 17 de diciembre de 2008),pp. 257-264.

41. Davis, S. y D. K. Mirick: «Circadian disruption,shift work and the risk of cancer: A summary of the evi-dence and studies in Seattle», Cancer Causes & Control,vol. 17, nº 4, mayo de 2006, pp. 539-545.

42. Franzese, E. y G. Nigri: «Night work as a possiblerisk factor for breast cancer in nurses: Correlation betweenthe onset of tumors and alterations in blood melatoninlevels», Prof Inferm, vol. 60, nº 2, abril-junio de 2007,pp. 89-93.

43. Costa, G., E. Haus, E. y R. Stevens: «Shift workand cancer – considerations on rationale, mechanisms, andepidemiology», Scandinavian Journal of Work, Environ-ment & Health, vol. 36, nº 2, 2010, pp. 163-179.

44. Garland, F. C., C. F. Garland, E. D. Gorham et al.:«Geographic variation in breast cancer mortality in theUnited States: A hypothesis involving exposure to solarradiation», Prev Med, vol. 19, nº 6, noviembre de 1990,pp. 614-622.

45. Sanzo, M., R. Colucci, M. Arunachalam et al.:«Stress as a possible mechanism in melanoma progression»,


40

Dermatol Res Pract, vol. 2010, (publicación electrónica:27 de mayo de 2010), pp. 483-493.

46. Saul, A. et al.: «Chronic stress and susceptibility toskin cancer», JNCI, vol. 97, nº 23, 7 de diciembre de 2005.

47. Lohmeier, L.: «Let the sun shine in», East West,julio de 1986, pp. 36-43.

48. Wu, J., R. T. Dauchy, P. C. Tirrell et al.: «Light atnight activates IGF-1R/ PDK1 signaling and accelerates tu-mor growth in human breast cancer xenografts», CancerResearch, vol. 71, nº 7, 1 de abril de 2011 (publicación elec-trónica: 10 de febrero de 2011), pp. 2622-2631.

49. Stevens, Richard et al.: «Artificial lighting in the in-dustrialized world: Circadian disruption and breast cancer»,Cancer Causes & Control, vol. 17, nº 4, 2006, pp. 501-507.

50. Schernhammer, E. S., F. Laden, F. E. Speizer et al.:«Rotating night shifts and risk of breast cancer in womenparticipating in the nurses’ health study», JNCI, vol. 93,nº 20, 17 de octubre de 2001, pp. 1563-1568.

51. Schernhammer, E. S., F. Laden, F. E. Speizer et al.:«Night-shift work and risk of colorectal cancer in the nur-ses’ health study», JNCI, vol. 95, nº 11, 4 de junio de 2003,pp. 825-828.

52. Reed, V. A.: «Shift work, light at night, and the riskof breast cancer», AAOHN Journal, vol. 59, nº 1, enero de2011 (publicación electrónica: 23 de diciembre de 2010),pp. 37-45.

53. Stevens, Richard et al.: «Meeting report: The roleof environmental lighting and circadian disruption in can-cer and other diseases», Environmental Health Perspecti-ves, vol. 115, nº 9, septiembre de 2007, pp. 1357-1362.

54. Verkasalo, P. K., K. Lillberg, R. G. Stevens et al.:«Sleep duration and breast cancer: A prospective cohortstudy», Cancer Research, vol. 65, nº 20, 15 de octubre de2005, pp. 9595-9600.

55. Andersen, M. L., D. A. Ribeiro, C. T. Bergamaschiet al.: «Distinct effects of acute and chronic sleep loss onDNA damage in rats», Progress in Neuro-Psychopharmaco-logy & Biological Psychiatry, vol. 33, nº 3, 30 de abril de 2009(publicación electrónica: 28 de febrero de 2009), pp. 562-567.


41

56. Ziemann, A. E., J. E. Allen, N. S. Dahdaleh et al.:«The amygdala is a chemosensor that detects carbon dioxi-de and acidosis to elicit fear behavior», Cell, vol. 139, nº 5,25 de noviembre de 2009, pp. 1012-1021.

57. Krieger, A. C., D. Green, M. T. Cruz et al.: «Pre-dictors of oxidative stress in heart failure patients withCheyne-Stokes respiration», Sleep & Breathing, 20 de no-viembre de 2010.

58. Billhult, A., C. Lindholm, R. Gunnarsson et al.: «Theeffect of massage on immune function and stress in womenwith breast cancer: A randomized controlled trial», Auto-nomic Neuroscience, vol. 150, nº 1-2, 5 de octubre de 2009(publicación electrónica: 18 de abril de 2009), pp. 111-115.

59. Billhult, A., C. Lindholm, R. Gunnarsson et al.:«The effect of massage on cellular immunity, endocrine andpsychological factors in women with breast cancer: A ran-domized controlled clinical trial», Autonomic Neuroscien-ce, vol. 140, nº 1-2, junio de 2008 (publicación electrónica:12 de mayo de 2008), pp. 88-95.

60. Hernandez-Reif, M., G. Ironson, T. Field et al.:«Breast cancer patients have improved immune and neuroen-docrine functions following massage therapy», Journal ofPsychosomatic Research, vol. 57, nº 1, julio de 2004, pp. 45-52.

61. Hernandez-Reif, M., G. Ironson, T. Field et al.:«Natural killer cells and lymphocytes increase in womenwith breast cancer following massage therapy», Int J Neu-rosci, vol. 115, nº 4, abril de 2005, pp. 495-510.

62. Noto, Y., M. Kudo y K. Hirota: «Back massagetherapy promotes psychological relaxation and an increasein salivary chromogranin A release», Journal of Anesthesia(J Anesth), vol. 24, nº 6, diciembre de 2010 (publicaciónelectrónica: 5 de agosto de 2010), pp. 955-958.

63. Noto, Y., M. Kitajima, M. Kudo et al.: «Leg massa-ge therapy promotes psychological relaxation and reinfor-ces the first-line host defense in cancer patients», Journal ofAnesthesia (J Anesth), vol. 24, nº 6, diciembre de 2010 (26de octubre de 2010), pp. 827-831.

64. Goodfellow, L. M.: «The effects of therapeuticback massage on psychophysiologic variables and immu-


42

ne function in spouses of patients with cancer», NursingResearch, vol. 52, nº 5, septiembre de-octubre de 2003,pp. 318-328.

65. Cassileth, B. R. y F. J. Keefe: «Integrative and be-havioral approaches to the treatment of cancer-related neu-ropathic pain», The Oncologist, vol. 15, suplemento 2, 2010,pp. 19-23.

66. Cassileth, B., C. Trevisan y J. Gubili: «Comple-mentary therapies for cancer pain», Current Pain andHeadache Report, vol. 11, nº 4, agosto de 2007, pp. 265-259.

67. Bensoussan, S.: Mieux vivre avec le cancer, Mon-treal, Les Éditions de l’Homme, 2009.

68. Schulz, S. y R. G. Laessle: «Associations of negati-ve affect and eating behaviour in obese women with andwithout binge eating disorder», Eating and Weight Disor-ders, vol. 15, nº 4, diciembre de 2010, pp. e287-e293.

69. Béliveau, Richard y Denis Gingras: Les alimentscontre le cancer, Quebec, Éditions Trécarré, 2005.

70. Béliveau, Richard y Denis Gingras: Cuisiner avecles aliments contre le cancer, Quebec, Éditions Trécarré,2009.

11. ¿Y si el enemigo fuera uno mismo?

1. www.cancer.org2. Leshan, L.: Cancer as a turning point, New York,

E. P. Dutton, 1990.3. Simonton, Carl: L’aventure d’une guérison, París,

Belfond, 1998.4. Bennette, G.: «Psychic and cellular aspects of isola-

tion and identity impairment in cancer: A dialectic of alie-nation», Ann NY Acad Sci, vol. 164, nº 2, 14 de octubre de1969, pp. 352-364.

5. Thomas, C. B.: «Closeness to parents and the familyconstellation in a prospective study of five disease states:suicide, mental illness, malignant tumor, hypertension, andcoronary heart disease», The Johns Hopkins Medical Jour-nal, vol. 134, 1973, pp. 251-270.


43

6. Corniou, Marine: «Cancer. Une maladie des origi-nes?», Science et Vie, abril de 2011, pp. 74-77.

7. Burmeister, M., M. G. McInnis y S. Zöllner: «Psy-chiatric genetics: Progress amid controversy», Nature Re-views Genetics, vol. 9, nº 7, julio de 2008, pp. 527-540.


9. Ventegodt, S., T. D. Hermansen, T. Flensborg-Madsen et al.:«Human development VII: A spiral fractalmodel of fine structure of physical energy could explaincentral aspects of biological information, biological organi-zation and biological creativity», Scientific World Journal,vol. 6, 14 de noviembre de 2006, pp. 1434-1440.

10. Laszlo, E.: The Interconnected Universe: Concep-tual Foundations of Transdisciplinary Unified Theory, Sin-gapur, World Scientific, 1995.

11. Kenny, P. A., G. Y. Lee y M. J. Bissell: «Targetingthe tumor microenvironment», Frontiers in Bioscience,vol. 12, 1 de mayo de 2007, pp. 3468-3474.

12. Rønnov-Jessen, L. y M. J. Bissell: «Breast cancerby proxy: Can the microenvironment be both the cause andconsequence?», Trends in Molecular Medicine, vol. 15, nº 1,enero de 2009 (publicación electrónica: 16 de diciembre de2008), pp. 5-13.


14. Beauregard, Mario y Denyse O’Leary: Du cerveauà Dieu, París, Guy Trédaniel Éditeur, 2008.

15. Lipton, Bruce H.: The Biology of Belief [audioli-bro], Sounds True, Incorporated, 2006.

16. Virk, G., G. Reeves, N. E. Rosenthal et al.: «Shortexposure to light treatment improves depression scores inpatients with seasonal affective disorder: A brief report», IntJ Disabil Hum Dev, vol. 8, nº 3, julio de 2009, pp. 283-286.

17. Trojak, B., J. C. Chauvet-Gelinier, B. Vergès et al.:«Significant increase in plasma thyroid-stimulating hor-mone during low-frequency repetitive transcranial magne-tic stimulation», The Journal of Neuropsychiatry and Clini-cal Neurosciences, vol. 23, nº 1, otoño de 2011, p. E12.


44

18. McCraty, Rollin: «The Energetic Heart: Bioelec-tromagnetic Communication Within and Between People»,capítulo de Clinical Applications of Bioelectromagnetic Me-dicine, dirigido por P. J. Rosch y M. S. Markov, New York,Marcel Dekker, 2004.

19. McFadden, Johnjoe: «Synchronous Firing and ItsInfluence on the Brain’s Electromagnetic Field Evidencefor an Electromagnetic Field Theory of Consciousness»,Journal of Consciousness Studies, vol. 9, nº 4, pp. 23-50.

20. Press, C., J. Cook, S. J. Blakemore et al.: «Dynamicmodulation of human motor activity when observing ac-tions», J Neurosci, vol. 31, nº 23, febrero de 2011, pp. 2792-2800.

21. Uithol, S., I. van Rooij, H. Bekkering et al.: «Un-derstanding motor resonance», Society for Neuroscience,4 de marzo de 2011, pp. 1-10.

22. Grinberg-Zylberbaum, J. y J. Ramos: «Patterns ofinterhemispheric correlation during human communication»,Int J Neurosci, vol. 36, nº 1-2, septiembre de 1987, pp. 41-53.


24. Nobili, R.: «Schrödinger wave holography in braincortex», Physical Review A, vol. 32, nº 6, diciembre de1985, pp. 3618-3626.

25. Nobili, R.: «Ionic waves in animal tissues», PhysicalReview A, vol. 35, nº 4, 15 de febrero de 1987, pp. 1901-1922.


27. Chopra, Deepak: Ageless Body, Timeless Mind: TheQuantum Alternative to Growing Old, Harmony Books,1994.


29. Jibu, M., S. Hagan, S. R. Hameroff et al.: «Quan-tum optical coherence in cytoskeletal microtubules: Impli-cations for brain function», BioSystems, vol. 32, nº 3, 1994,pp. 195-209.

30. Lipton, Bruce: The Biology of Belief, California,Hay House, 2005.


45

31. Yan, X., J. Han, Z. Zhang et al.: «Lung cancer A549cells migrate directionally in DC electric fields with polari-zed and activated EGFRs», Bioelectromagnetics, vol. 30,nº 1, enero de 2009, pp. 29-35.


33. Mycielska, M. E. y M. B. Djamgoz: «Cellular me-chanisms of direct-current electric field effects: Galvano-taxis and metastatic disease», Journal of Cell Science (J CellSci), vol. 117, nº 9, 1 de abril de 2004, pp. 1631-1639.

34. Djamgoz, M. B. A., M. Mycielska, Z. Madeja et al.:«Directional movement of rat prostate cancer cells in di-rect-current electric field: Involvement of voltagegated Na+

channel activity», J Cell Sci, vol. 114, nº 14, julio de 2001,pp. 2697-2705.

35. Tolle, Eckhart: A New Earth, New York, Plume,2005. [Hay edición española: Un mundo nuevo ahora, Bar-celona, Debolsillo, 2008.]

36. Burgio, G. R.: «Biologic individuality between ge-netics and environment: On the formation of the biologicego», Monatsschrift Kinderheilkunde, vol. 133, nº 4, abrilde 1985, pp. 201-206.

37. Ainsworth, Claire: «Cell biology: The story of I»,Nature, vol. 440, 6 de abril de 2006 (publicación electróni-ca: 5 de abril de 2006), pp. 730-733.

38. Servan-Shreiber, David: Anticancer, París, Édi-tions Robert Laffont, 2007.

39. Petrowski, Nathalie: «Guérir à en mourir», LaPresse, 25 de junio de 2011.

40. Servan-Schreiber, David: On peut se dire au revoirplusieurs fois, París, Éditions Robert Laffont, 2011. [Hayedición española: Hay muchas maneras de decir adiós, Bar-celona, Espasa, 2011.]

Conclusión

1. http://www.who.int/mediacentre/news/releases/2003/pr27/fr/index.html


46

2. Bennette, G.: «Psychic and cellular aspects of isola-tion and identity impairment in cancer: A dialectic of alie-nation», Ann NY Acad Sci, vol. 164, nº 2, 14 de octubre de1969, pp. 352-364.

3. Rechis, R., C. Neal y D. McGoldric: «Livestrongat school: Changing classroom talk about cancer», Jour-nal of Cancer Education, vol. 25, nº 1, marzo de 2010,pp. 127-128.

4. Pelletier, K. R.: «A review and analysis of the clini-cal- and cost-effectiveness studies of comprehensive healthpromotion and disease management programs at the work-site: 1998-2000 update», American Journal of Health Pro-motion, vol. 16, nº 2, noviembre-diciembre de 2001,pp. 107-116.

5. Lazarou, J., B. H. Pomeranz y P. N. Corey: «Inci-dence of adverse drug reactions in hospitalized patients: Ameta-analysis of prospective studies», JAMA, vol. 279,nº 15, 15 de abril de 1998, pp. 1200-1205.

6. Shealy, Norman: Soul Medicine, California, Ener-gy Psychology Press, 2006.

7. Lemay, E.: «Un record d’antidépresseurs», LeJournal de Montréal, 6 de octubre de 2009, p. 5.

8. Yang, W., T. Staps y E. Hijmans: «Existential crisisand the awareness of dying: The role of meaning and spiri-tuality», Omega, vol. 61, nº 1, 2010, pp. 53-69.


10. Ramondetta, L. M. y D. Sills: «Spirituality in gyne-cological oncology: A review», International Journal ofGynecological Cancer, vol. 14, nº 2, marzo-abril de 2004,pp. 183-201.

11. Perreault A. y F. F. Bourbonnais: «The experienceof suffering as lived by women with breast cancer», IntJ Palliat Nurs, vol. 11, nº 10, octubre de 2005, pp. 510,512-519.

12. Coward, D. D.: «The lived experience of self-transcendence in women with advanced breast cancer»,Nursing Science Quarterly, vol. 3, nº 4, invierno de 1990,pp. 162-169.


47

13. Breitbart, W.: «Spirituality and meaning in sup-portive care: Spirituality —and meaning— centered grouppsychotherapy interventions in advanced cancer», Suppor-tive Care in Cancer, vol. 10, nº 4, mayo de 2002 (publica-ción electrónica: 28 de agosto de 2001), pp. 272-280.

14. White, M. y M. Verhoef: «Cancer as part of the jour-ney: The role of spirituality in the decision to decline con-ventional prostate cancer treatment and to use complemen-tary and alternative medicine», Integr Cancer Ther, vol. 5,nº 2, junio de 2006, pp. 117-122.

15. Carlson, L. E. et al.: «One-year pre-post interven-tion follow-up of psychological, immune, endocrine andblood pressure outcomes of mindfulness-based stress re-duction (MBSR) in breast and prostate cancer outpatients»,Brain Behav Immun, vol. 21, nº 8, 2007, pp. 1038-1049.

16. Witek-Janusek, L. et al.: «Effect of mindfulness ba-sed stress reduction on immune function, quality of life andcoping in women newly diagnosed with early breast can-cer», Brain Behav Immun, vol. 22, nº 6, agosto de 2008,pp. 969-981.

17. Matchim, Y.: «Measuring the psychological impactof mindfulness meditation on health among patients withcancer: A literature review», ONF, vol. 34, nº 5, 2007,pp. 1059-1066.

18. Coker, K.: «Meditation and prostate cancer: Inte-grating a mind/body intervention with traditional thera-pies», Seminars in Urologic Oncology, vol. 17, nº 2, 1999,pp. 111-118.

19. Ando, M.: «The efficacy of mindfulness-based me-ditation therapy on anxiety, depression, and spirituality inJapanese patients with cancer», Journal of Palliative Medi-cine, vol. 12, nº 12, 2009, pp. 1091-1094.

20. Elkins, G., W. Fisher, y A. Johnson: «Mind-bodytherapies in integrative oncology», Current TreatmentOptions in Oncology, vol. 11, nº 3-4, diciembre de 2010,pp. 128-140.

21. Ahmed, N., S. Ahmedzai, V. Vora et al.:«Supporti-ve care for patients with gastrointestinal cancer», CochraneDatabase of Systematic Reviews, nº 3, 2004.


48

22. Jacobsen, P. B.: «Clinical practice guidelines forthe psychosocial care of cancer survivors: Current statusand future prospects», Cancer, vol. 115, suplemento 18,15 de septiembre de 2009, pp. 4419-4429.

23. Berger, Ann et al.: Principles and practises of pallia-tive care and supportive oncology, Filadelfia, LippincottWilliams & Wilkins, 2007.

24. Sinclair, S., M. Mysak y N. A. Hagen: «What arethe core elements of oncology spiritual care programs?»,Palliative & Supportive Care, vol. 7, nº 4, diciembre de2009, pp. 415-422.

25. Cassileth, B. R. y F. J. Keefe: «Integrative and be-havioural approaches to the treatment of cancer-relatedneuropathic pain», vol. 15, suplemento 2, 2010, pp. 19-23.

26. Cassileth, B., C. Trevisan y J. Gubili: «Comple-mentary therapies for cancer pain», Current Pain andHeadache Report, vol. 11, nº 4, agosto de 2007, pp. 265-269.

Lecturas sugeridas

1. Epplein, M.: «Quality of life after breast cancerdiagnosis and survival», J. Clin. Oncology, vol. 29, nº 4, 1 defebrero de 2011, pp. 406-412.

2. Hara, M. R.: «A stress response pathway regulatesDNA damage through ß2-adrenoreceptors and ß-arrestin-1»,Nature, vol. 477, nº 7364, 21 de agosto de 2011, pp. 349-353.

3. Zainal, N. Z. et al.: «The efficacy of mindfulness-based stress reduction on mental health of breast cancer pa-tients: A meta-analysis», Psychooncology, DOI: 10.1002/pon. 3171, 7 de septiembre de 2012.

4. Lutgendorf, S. K.: «Social influences on clinicaloutcomes of patients with ovarian cáncer», J. Clin. Oncol.,vol. 30, nº 23, 10 de agosto de 2012 (publicación electrónica:16 de julio de 2012), pp. 2885-2890.

5. Lutgendorf, S. K.: «Social isolation is associated withelevated tumor norepinephrine in ovarian carcinoma pa-tients», Brain Behav. Immun., vol. 25, nº 2, febrero de 2011(publicación electrónica: 16 de octubre de 2010), pp. 250-255.


49

6. Antoni, M. H.: «Psychosocial intervention effectson adaptation, disease course and biobehavioral processes incáncer», Brain Behav. Immun., vol. 30, suplemento, 15 demarzo de 2013 (publicación electrónica: 22 de mayo de 2012),pp. S88-S98.

7. Medeiros, P. J.: «Neuropeptide Y stimulates prolife-ration and migration in the 4T1 breast cancer cell line», Int.J. Cancer., vol. 131, nº 2, 15 de julio de 2012, pp. 276-286.

8. Steliarova-Foucher, E.: «Geographical patterns andtime trends of cancer incidence and survival among childrenand adolescents in Europe since the 1970s (the ACCIS pro-ject): An epidemiological study», Lancet, vol. 364, nº 9451,11-17 de diciembre de 2004, pp. 2097-2015.

9. Biegler, K. A.: «Longitudinal Change in TelomereLength and the Chronic Stress Response in a RandomizedPilot Biobehavioral Clinical Study: Implications for Can-cer Prevention», Cancer Prev. Res. (Phila), vol. 5, nº 10, oc-tubre 2012 (publicación electrónica: 24 de julio de 2012),pp. 1173-1182 10 de septiembre de 2012.

10. «Stress et cancer»: http://www.mdanderson.org/newsroom/cancer-newsline/cancer-newsline-topics/2011/cancer-newsline-can-stress-cause-cancer-.html

11. Presentación de la oncología integrativa a cargodel Dr. Lorenzo Cohen: http://www.youtube.com/watch?v=QXzY4ox7kTM



Documents

Notas - planetadelibros.com.ar€¦ · 1 Notas Prefacio 1. Abrams,D.:IntegrativeOncology[Oncologíainte- grativa],OxfordUniversityPress,2009. 2. Dhabhar, F. S. et al.: «High-anxious